CT Clarity magazine - GE Healthcare en France
Transcription
CT Clarity magazine - GE Healthcare en France
GE Healthcare clarity CT the m a g a z i ne of C T • NOVEMBER 2011 Delivering Quality Care with the New Optima CT660: From Vision to Reality Pediatric Hospitals Bring Low-dose CT to the Middle East Veo: Understanding the Impact of Iterative Reconstruction Page 12 Page 39 Page 54 imagination at work Apple ta b l e o f c o n te n t s GE Healthcare News: Optima CT660: Taking Performance to a Whole New Level page 8 Customer Spotlight: Seeing Beyond the Naked Eye page 16 Clinical Value: High-Definition CT Improves Triage and Door-totreatment Times in Emergency Radiology page 34 GE Healthcare News Welcome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 A CT Designed for Broader Access. . . . . . . . . . . . . . . . . . . . . . . . . 9 CT Clarity, the Magazine of CT, Goes Digital . . . . . . . . . . . . . . . . . 5 Delivering Quality Care: From Vision to Reality . . . . . . . . . . . . 12 GE Launches New CT Low-dose Webinar Series. . . . . . . . . . . . . 5 Seeing Beyond the Naked Eye . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 Customer Spotlight MD Connect: Connecting Your Oncology Team With Applications… Anywhere. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 Low-dose CT Coming to Brazil . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 Dose Check Aids Hospitals in Regulating Patient Dose. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 General Electric to Expand in Russia With New Joint Ventures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Optima CT660: Taking Performance to a Whole New Level. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Publications Team GE Contributors Kelley Knutson & Jodi Young CT Clarity Editors CT Education Managers Andrew Ackerman CT Marketing Manager, Performance Segment, Americas Jennifer Ma Global Marketing Communications Leader CT and Advantage Workstation Olivier Adda CT Super Premium Strategic Product Manager, Europe, Middle East & Africa Mary Beth Massat Writer / Editorial Consultant Nilesh Shah Chief Marketing Officer, CT Integré Design/Production Clinical Value Meeting the Clinical Need for Low-dose Cardiac Studies. . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 Implementing Ultra-low Dose CT with Veo at University Hospital, Brussels. . . . . . . . . . . . . . . . . . . . . . . . . . . 21 BrightSpeed Elite with IQ Enhance Delivers Speed and Clarity in the Carolinas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 Khodor Berro CT Modality Sales Specialist, Kingdom of Saudi Arabia Nitin Bhardwaj Clinical Applications Specialist, CT, India Chuck Bisordi CT Product Development Specialist Benjamin Fox Global Public Relations Manager Enrique Garcia-Muñiz CT Marketing Manager, Latin America Laurent Guiral CT & AW Cardiac Clinical Leader, Europe, Middle East & Africa Dr. Karthik Anantharaman CT Marketing Manager, South Asia Valerie Brissart CT Marketing Director, Europe, Middle East & Africa Christophe Argaud Modality Manager, CT, France Eugene Charleston AW Server Product Leader DeAnn Haas CT Marketing Manager, Leadership Segment, Americas Paul Ayestaran Advanced Applications Specialist, Europe, Middle East & Africa Kenneth Denison, PhD CT Dose Leader John Jaeckle Regulatory Affairs Manager, MI & CT Melissa Desnoyers Clinical Project Manager, CT Melissa Megumi Shiraishi Kuriki CT Advanced Applications Specialist, Latin America Chelsea Beeler Communications Manager Paul Edwards AW Product Manager Jennifer Esposito Director, Dose Services, Americas 2 Amanda Fox CT Product Developent Specialist A GE Healthcare CT publication • www.ctclarity.com Elena Lim CT Product Marketing Leader, Value Segment ta b l e o f Case Study: Confirming a Diagnosis of Double Aortic Arch in a Newborn page 46 Technical Innovation: Photon Counting: A New CT Technology Just Over the Horizon page 64 High-Definition CT Improves Triage and Door-to-treatment Times in Emergency Radiology . . . . . . . . . 34 Pediatric Hospitals Bring Low-dose CT to the Middle East. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 Beyond the Scan: Comprehensive Dose Management Services and Solutions page 68 Technical Innovation Emerging Applications in Musculoskeletal CT Imaging. . . . . 27 4D CT With Respiratory Gating Helps Locate and Track Lesions to Reduce Target Volumes . . . . . . . . . . . . . . 32 contents Understanding the Impact of Iterative Reconstruction . . . . 54 Integration and Information the Cornerstone of Radiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60 Photon Counting: A New CT Technology Just Over the Horizon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64 Beyond the Scan Case Study Low-dose CTA With ASiR. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 Comprehensive Dose Management Services and Solutions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68 Confirming a Diagnosis of Double Aortic Arch in a Newborn. . . . . . . . . . . . . . . . . . . . . . . . . 46 Does my Patient Need a CT Scan? . . . . . . . . . . . . . . . . . . . . . . . 70 Critical Low-dose Neuro Imaging with ASiR. . . . . . . . . . . . . . . 48 Worldwide Education. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73 Multi-modality Oncology Workflow for Comprehensive Follow-up and Treatment. . . . . . . . . . . . . 50 Colleen Lockwood CT Global Marketing Manager Gobinda Pal Product Specialist, CT, India Stephen Slavens Regulatory Affairs Director, AW Dusty Majumdar, PhD CT Marketing Manager, Premium Segment, Americas Karen Procknow CT Product Development Specialist J. Eric Stahre General Manager, Global Premium CT Holly McDaniel CT Product Development Specialist Linda Pucek CT Segment Marketing Manager, Oncology, Americas Laurent Stefani Global AW Marketing Manager Andrew Menden Regulatory Affairs Leader Rick Raby Sales Specialist, CT Phil Moh CT Masters Series Coordinator Muhammad Sadiqur Rahman Product Specialist, CT, Bangladesh Daniel Morris CT Global Marketing Manager Sundar RK CT Clinical Applications Manager, India Vincent Norlock CT Global Marketing Manager Alyssa Nowak CT Product Development Specialist Christoph Obermeier CT Clinical Education Manager, Europe, Middle East & Africa Dario Salvadori CT Performance & Value Strategic Product Manager, Europe, Middle East & Africa Mark Semisch Lead Counsel, GE Healthcare Systems Andras Szentmiklossy Global Product Manager, Oncology Cristian Toader, PhD CT Premium Strategic Product Manager, Europe, Middle East & Africa Melhem Younan CT Clinical Leader, EAGM Pengcheng Zhang Marketing Manager, Oncology Patricia Zoltowski CT Education Leader *Trademark of General Electric Company. iPad and iPhone are registered trademarks of Apple, Inc. Android is a trademark of Google, Inc. © 2011 General Electric Company, doing business as GE Healthcare. All rights reserved. The copyright, trademarks, trade names and other intellectual property rights subsisting in or used in connection with and related to this publication are the property of GE Healthcare unless otherwise specified. Reproduction in any form is forbidden without prior written permission from GE Healthcare. LIMITATION OF LIABILITY: The information in this magazine is intended as a general presentation of the content included herein. While every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinion or statements occur, GE cannot accept responsibility for the completeness, currency or accuracy of the information supplied or for any opinion expressed. Nothing in this magazine should be used to diagnose or treat any disease or condition. Readers are advised to consult a healthcare professional with any questions. Products mentioned in the magazine may be subject to government regulation and may not be available in all locations. Nothing in this magazine constitutes an offer to sell any product or service. www.gehealthcare.com/ct • November 2011 3 ge hea lthca r e n e w s welcome Steve Gray, Vice President and General Manager, Computed Tomography, GE Healthcare Leadership, Excellence in Patient Care, Productivity Three commitments that guide both GE Healthcare CT and our clinical partners In this issue of CT Clarity, we share our customers’ stories on how these commitments improve their day-to-day clinical practice and research: How they are achieving high-quality diagnostic exams with lower dose thanks to ASiR* and Veo*; what the impact of high-definition imaging means for their patients’ diagnoses and treatments; how implementing tools can enhance workflow and raise clinical productivity to new levels while expanding clinical collaboration; and, why it is important to embrace the next era of CT innovation with spectral dual energy and low-dose imaging. We have only just begun. Across the industry—from manufacturer to provider—we are all more cognizant of the importance of ensuring that CT imaging produces substantial benefits. In fact, the ability to reduce dose without affecting image quality is the first thing our customers say they need. Together, with our clinical partners, we are exploring the future of low-dose imaging. In one of the first global, multi-site, clinical trials of its kind, Dr. Rendon Nelson and Dr. Ehsan Samei are leading the effort to determine, by body part and anatomy, the dose reduction potential of Veo. Their initial impression of Veo—it’s a positive game changer. Professor Johan de Mey also shares his experience with Veo. It is interesting to note that two stories—from opposite ends of the world—convey a similar message: the value of Veo extends beyond its low-dose capabilities. While the images Veo produces are clearly different from filtered back projection (FBP), these clinicians report seeing more information in the Veo images than in FBP. Couple that with the potential to conduct CT scans at previously unattainable low-dose levels, and the future of CT looks promising indeed. Our low-dose initiative involves more than just Veo and ASiR, however. We’re introducing DoseWatch in conjunction with comprehensive dose management services and solutions. At GE, our low-dose CT approach is multi-faceted, including technology, education, training, and implementation. We’re excited to provide you with an array of tools that will help you conduct high-quality CT studies at ultra-low doses. The near future is even brighter. We continue to build upon the foundation of Gemstone* Spectral Imaging (GSI) and high definition (HD) to address current challenges in CT cardiac imaging. Additionally, this year at RSNA we will display the Discovery* CT750 HD FREEdom Edition (commercially available only outside of the US), which is being designed to provide a new standard in cardiac imaging. As excited as we are for tomorrow’s advancements, we understand that there are clinical demands and questions that our customers need addressed today. Our customers have told us they need better CT imaging workflows that enhance productivity and clinical collaboration. Last issue, we introduced you to the Dexus* workflow. In this edition, Dr. William Shuman shares his experience with Dexus and why it is important not just for radiology productivity, but for enhancing access to clinical information and applications in any location, at any time. You can also read Dr. Valerie Laurent’s case study on how OncoQuant*, part of the Dexus family, has made a difference in oncology follow-up and treatment. GE’s investment in CT spans the world. We can be a better leader by listening to our customers from every corner of the globe, sharing the challenges they face each day, and addressing them through innovation, research, and development. For many clinicians throughout the world, offering access to CT imaging is the challenge. The Brivo* CT315§ and CT325§ are helping to bridge this gap with high-quality, cost-efficient CT systems. Our customers in India and China share their initial experiences with the Brivo CT325 and the impact on patient care. And, you’ll read how hospitals are able to take their performance to a whole new level with our exciting new Optima* CT660. Customers in India, South America, France, and the US are using the healthymagination and ecomagination validated Optima CT660 to improve their workflow, increase patient and referring physician demand, enhance patient care, and optimize dose with ASiR. Together with you, great care by design is attainable for all countries, cultures, and people. And, if you can’t join us at RSNA 2011, I hope you’ll join us virtually at www.gehealthcare.com to learn more about how we can all make an impact on the future of healthcare through CT imaging. Read on, enjoy, and thanks for your continued support. And, don’t forget to check out the new digital edition of CT Clarity. n *Trademark of General Electric Company. § 4 A GE Healthcare CT publication • www.ctclarity.com Brivo CT315 and CT325 are not for sale in the United States. Not cleared by the US FDA. a nn o u n c e m e n t s g e h e a lt h c a r e n e w s CT Clarity, the Magazine of CT, Goes Digital Get the latest CT clinical, technical, and operational news digitally—on the Web, iPad, iPhone, or Android tablet and phone. CT Clarity is now available online at www.ctclarity.com. Download the tablet and smartphone applications free of charge at the Apple Store (www.apple.com) or Android Market Apps (www.market.android.com). Or, simply scan the QR codes with your smartphone! Don’t miss exclusive content that can’t be found anywhere else— videos, interviews, and expanded clinical images and cases. Easily search for keywords and hot topics to locate the content that interests you the most. Share links to articles via email or quick links to social networks. You can still download the magazine as a PDF for offline reading. Watch for updates to your app with the latest news from GE CT. n ctclarity.com Android Apple » Download your CT Clarity magazine today at www.ctclarity.com or get your free CT Clarity app at www.apple.com and www.market.android.com. GE Launches New CT Low-dose Webinar Series For over three decades, GE has been empowering clinicians and technologists with radiation dose-reducing techniques. This commitment included innovative education offerings that enable our customers to maximize their use of these technologies to image at doses consistent with the ALARA principle. GE will continue to offer dose education through accredited webinars that feature a variety of experts who share their experience on reducing radiation dose. This content is now available to our customers via the new CT Low-dose Webinar series. • Fundamentals of CT and Radiation Dose; • Dose Reduction Techniques for Cardiac CT; • Neuroimaging Considerations; and • Techniques for Reducing CT Radiation Dose. n GE offers six modules approved by the ASRT for Category A CE credits (4.5 total credits): • Radiation Dose—Current Issues and New Techniques; • Reducing Radiation Risk in CT Scans for Children; » More information on the Low-dose Webinar Series can be found at www.gehealthcare.com/ctedu/dosewebinar. www.gehealthcare.com/ct • November 2011 5 ge hea lthca r e n e w s a n n o u n ce m e n t s MD Connect: Connecting Your Oncology Team With Applications… Anywhere Recent innovations in oncology imaging and treatment have made it possible to treat cancer more effectively. Specifically, more precise and targeted treatment, coupled with earlier detection, has led to a remarkable improvement in five-year, disease-free survival rates for cancer patients. Yet, these new technologies generate more sophisticated and detailed information that is used throughout the care cycle, requiring clinicians to utilize different workstations and applications. For caregivers/clinicians, this translates to a more complex workflow for processing, connecting, and collaborating across the continuum of oncology care. via virtually any networked computer to the complete suite of oncology applications from any location or department. As part of the Dexus workflow environment, MD Connect provides fast access to a complete portfolio of oncology and radiology applications—all on one platform. These applications include: sophisticated tools for virtual simulation; 3D image fusion; 4D motion management; tools to diagnose, stage, and monitor treatment effectiveness; and more. The tools are designed to transform the complex into routine and the routine into more efficient. MD Connect is a new, innovative, thin client solution designed for oncology that addresses the need for a seamless workflow from scan to plan and monitors treatment effectiveness to help improve productivity across the cancer care continuum. Powered by the GE AW Server, it enables plug-and-play access MD Connect integrates with the Eclipse™ treatment planning platform from Varian Medical Systems on one desktop and with other DICOM-based treatment planning platforms. Compliant with the IHE-RO standard, MD Connect interoperates across a multitude of different oncology systems and manufacturers. n Eclipse is a trademark of Varian Medical Systems, Inc. Low-dose CT Coming to Brazil In a move that will broaden the availability and accessibility of low-dose CT imaging across Brazil, DASA (Diagnosticos da America SA) has ordered 21 low-dose CT scanners from GE Healthcare. The sale includes BrightSpeed and Optima systems featuring ASiR* and will be installed during the 4th quarter of 2011 and 1st quarter of 2012. The São Paulo-based company is the largest medical diagnostics provider in Latin America, operating 496 centers in Brazil, with 12,000 employees in 12 of Brazil’s 26 states. According to Iugiro Roberto Kuroki, MD, Director, Medical Diagnostic Imaging and Radiology at DASA, “The purchasing of low-dose CT equipment is in synergy with the company’s philosophy of being a pioneer in quality and medical responsibility and ensuring patient access to state-of-the-art diagnostic testing. DASA believes that CT plays a key role in medicine today, and the 6 A GE Healthcare CT publication • www.ctclarity.com ASiR technology is another CT advancement that may offer dose reductions for cardiac and whole-body exams.”** Dr. Kuroki believes their new, low-dose CT systems will contribute to the company’s broader vision of modernizing technology, standardizing operations, and offering responsible, high-quality imaging. “We looked for a company that shared our philosophy and long-term vision, demonstrating commitment to the sustainability and growth of the project,” says Dr. Kuroki. “In GE, we found a partner that fulfilled all of our expectations and offered a great cost/benefit ratio for the size of our project with the Optima and BrightSpeed CT systems.” n **In clinical practice, the use of ASiR may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. a nn o u n c e m e n t s g e h e a lt h c a r e n e w s Dose Check Aids Hospitals in Regulating Patient Dose As a leader in providing low-dose CT applications, GE Healthcare invests in initiatives designed to help radiologists and medical imaging professionals tailor exams to patients of all ages and conditions. Our commitment to patient safety continues with the implementation of Dose Check at no cost on most GE CT scanners. The US Food and Drug Administration has asked all CT manufacturers to pre-populate the CTDIvol Alert Value at 1,000 mGy. GE’s Dose Check also provides an option to set a second Alert Value that is applied for exams on patients under an age threshold determined by each imaging facility. Dose Check is part of the Medical Imaging & Technology Alliance’s (MITA) Radiation Dose Reduction Plan and CT Dose Check global initiative. It provides alerts and notifications to scanner operators when pre-defined radiation dose levels—as determined and set by the facility—will be exceeded. There are two levels of thresholds: Notification Values and Alert Values. Notification Values apply to a single image series (e.g. a single helical series) while Alert Values apply to a complete exam. Both CTDIvol and/or DLP (Dose Length Product) values can be set. GE Healthcare representatives will be contacting facilities to schedule the installation of this FMI (Field Modification Instruction) on select scanners and deliver an informational packet and training materials that include: • Multi-language, updated operator’s manual; • Computer-based training materials: Dose Check Training Tutorial & Video CDs; and • Dose Check Quick Guide for console-side reference. n » For additional information on Dose Check and a list of scanners scheduled to receive it, please visit www.gehealthcare.com/LowerDoseByDesign. General Electric to Expand in Russia With New Joint Ventures GE expanded its position in one of the world’s fastest growing markets by finalizing agreements to set up two new joint ventures—an Energy JV and Healthcare JV—in Russia. Russian Prime Minister Vladimir Putin attended the signing ceremony during the 10th International Investment Forum that took place Sept. 16, 2011 in Sochi, Russia. The Healthcare JV agreement was signed by RUSSIAN TECHNOLOGIES Deputy General Director Dmitry Shugayev and GE Chairman and CEO Jeffrey Immelt. This JV will manufacture, assemble, sell, and service a wide range of high-tech medical diagnostic equipment. “The establishment of these joint ventures is a positive development for both GE and Russia,” Immelt said. “We are very excited about this long-term opportunity that firmly establishes GE’s business in Russia and reaffirms our global leadership in the energy and healthcare sectors. Our expansion in Russia reflects GE’s global approach to growth. It draws on leading-edge R&D, engineering, and manufacturing expertise from GE centers throughout the world even as it meets the needs and creates value in our customers’ home markets.” The healthcare joint venture between GE and RUSSIAN TECHNOLOGIES will start with the production of CT scanners and then expand to other diagnostic medical equipment. The joint venture may use the recently established joint GE Healthcare— Medical Technologies Ltd. CT scanner assembly facility in Moscow. In May 2010, GE Healthcare installed the first Russian-assembled 16-slice CT scanner in one of Moscow’s hospitals. The company expects to supply over 60 more CTs to hospitals throughout Russia by year-end 2011. The Russian government plans to spend more than $30 billion from 2011 to 2014 on healthcare. GE estimates current Russian demand for CT scanners alone stands at 3,000 units. n www.gehealthcare.com/ct • November 2011 7 ge hea lthca r e n e w s a n n o u n ce m e n t s Optima CT660: Taking Performance to a Whole New Level Hospitals today are faced with having to do more with less. In the US, a global recession, healthcare reform, changes in the delivery of patient care including the emergence of Accountability Care Organizations, the need for low-dose initiatives, and lower reimbursement have led hospitals to reevaluate purchasing patterns and priorities. As a result, hospital administrators are seeking greater value in their capital equipment purchases. They want to maximize returnon-investment, achieve a lower total cost of ownership, and create an avenue for growth by developing additional service lines that help attract new patient groups. Growth is an important consideration in selecting a CT system that provides high-quality images and superior workflow across a plethora of studies—cardiac, neuro, routine, and trauma/emergency—while opening up new avenues for profitable growth. Hospital administrators often seek a system that can help differentiate their services from the competition. The recently US FDA-cleared Optima CT660—a 64-channel detector that is scalable from 32 to 128 slices and GE healthymagination and ecomagination validated—fulfills these needs. It addresses the key requirements that many C-suite hospital administrators seek from new equipment acquisitions: patient care, financial performance, operational excellence, and market growth. The Optima CT660 consumes up to 60% less energy than previous GE CT systems and boasts a 15% lower siting requirement compared to other 64-channel detector scanners. Lower operational costs translate to savings of potentially tens of thousands of dollars over the life of the product. Plus, implementing a scanner that emits up to 60% less carbon emission on the US grid is one step toward becoming a “green” hospital. Financial performance continues with service. GE’s service, ranked No. 1 in service performance for CT systems by IMV Limited in 2011,1 provides the highest number of CT field engineers of any OEM. OnWatch Remote Services can often resolve 45% of a CT scanner’s service issue(s) remotely. Operational excellence is the key to market growth. The Optima CT660 provides a comprehensive suite of clinical capabilities—starting with the GE-exclusive ASiR for low-dose imaging across all anatomies. ASiR has been evaluated for its lower-dose capabilities in over 75 published studies. Ten million patients in more than 500 facilities worldwide have been scanned using ASiR.** Key applications on the Optima CT660 include: lowdose cardiovascular imaging with SnapShot* Pulse and consistent 0.625 mm data acquisition in CT Angiography; VolumeShuttle* perfusion; Volume Helical Shuttle (VHS) for perfusion studies up to 12 cm; Lung VCAR* and CTC Pro3D EC applications for lesion detection, analysis, and follow-up; autosegmentation tools matching datasets to MR and PET/CT; and, fast, efficient, one-touch workflow for emergency departments. The 12-inch Xtream display on the gantry shows patient information, protocol settings, and the ability to play relaxing videos. Automatic patient positioning and a synchronized starting of the exam and injection further streamline the study so facilities can maximize patient throughput. The Optima CT660 also delivers a comfortable patient experience. The Optima CT660 brings together workflow efficiency, diagnostic power, and lower equipment and operational costs to address a new era of exceptional patient care, financial performance, and operational excellence. n References: 1. IMV ServiceTrak* Imaging CT Systems 2011 Report. IMV Medical Information Division, Des Plaines, IL. **In clinical practice, the use of ASiR may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. 8 A GE Healthcare CT publication • www.ctclarity.com » To view a video about the Optima CT660, please visit www.ctclarity.com/ctclarity/201111#pg8. brivo ct325 in india C U S T O M E R customer spotlight S P O T L I G H T A CT Designed for Broader Access By Pranabananda Goswami, DMRD, MD, Jayati Bardhan, MD, Consulting Radiologists, and Mr. Govind Agarwal, Midnapore Diagnostics Pvt. Ltd. Access to healthcare throughout India is improving as a result of Public-Private Partnerships (PPP). An initiative by the Department of Health & Family Welfare of the Government of West Bengal (WB) aims to make healthcare facilities available in the district with the continued development of PPPs through the procurement cell West Bengal Medical Services Corporation Ltd. (WBMSC). The Brivo§ CT325, a GE Healthcare healthymagination-validated CT scanner, is a key contributor for increasing access to advanced CT imaging in the state of West Bengal, India. Pranabananda Goswami, DMRD, MD Mr. Govind Prasad Agarwal, Founder, Midnapore Diagnostics Pvt. Ltd. Brivo CT325 streamlines patient positioning, which often cuts in half the time it takes us to position the patient in the gantry. § Brivo CT325 is not for sale in the United States. Not cleared by the US FDA. www.gehealthcare.com/ct • November 2011 9 C u s t o m e r S p o t l i ght b r i v o ct 3 2 5 i n i n d i a C US T OM E R Volume-rendered 3D image is from digital tilt raw data. CT angiography of the Circle of Willis with faster coverage and high spatial resolution. SPO T LI G H T A unique sub-mm high resolution CT image of the inner ear. India’s first Brivo CT325 was installed at our facility, Midnapore Diagnostics Pvt. Ltd. (MDPL), within the premises of R G Kar Medical College & Hospital (Kolkata). Situated in the heart of Kolkata, the hospital is a PPP venture between the Government of West Bengal State and MDPL. Mr. Govind Prasad Agarwal founded MDPL in 2002 with the objective of providing access to radiology diagnostic facilities (CT & MRI) for the common people. In February 2011, the new Brivo CT325 replaced a single-slice CT. On average, we are performing 45 CT cases each day, which exceeds 1,200 cases each month. In July 2011, we scanned Midnapore Diagnostics Pvt. Ltd. within the premises of R G Kar Medical College & Hospital. 10 A GE Healthcare CT publication • www.ctclarity.com Volume-rendered 3D image illustrates a bone tumor in the pelvis. 1,500 patients on the Brivo CT325, a record for monthly CT scans at our facility. We are now very comfortable doing more than 60 cases a day (including 25 to 30 body imaging cases), which has substantially improved patient care. This was previously not possible with our single-slice CT scanner. We anticipate that we will be able to sustain similar capacities in subsequent months, particularly due to the fact we’ve encountered no unplanned downtime since the installation. brivo ct325 in india Portography study demonstrates Volume-rendered 3D image of the kidneys shows good excellent low contrast detectability. spatial resolution. One of our requirements for a new CT scanner was faster scanning time so that our radiology team could handle higher patient volumes. Brivo CT325 streamlines patient positioning, which often cuts in half the time it takes us to position the patient in the gantry. Our technologists are also impressed with the compact operating console and additional filming formats. After six months of use, we are very satisfied with the speed of the system and the quality of its images. Additionally, we find the new unique Digital Tilt scan technique helps generate excellent MPRs (Multi Planar Reformats) and display as routine tilted images. We do not have to conduct another scan just to obtain different reconstructions. And, the new innovative table helps us complete the cases quickly and efficiently. customer spotlight MPR depicts the hip and head of femur. Perhaps most important to the sustainability of our PPP, the volume-rendered 3D and HRCT (asymmetric scan) images are catching the attention of many referring physicians. In conclusion, we feel that the Brivo CT325 imaging capabilities fulfill the various clinical needs of healthcare facilities like ours. Its high image quality and dose-conscious design—combined with a wide variety of proven, advanced applications—help us make efficient and confident diagnoses across anatomies— from the head down to the toes. This helps us provide better support to other departments in the hospital and to our referral doctors. Brivo CT325 thus lives up to its claim of extending quality care to more people at an affordable cost. n Its high image quality and dose-conscious design— combined with a wide variety of proven, advanced applications—help us make efficient and confident diagnoses across anatomies—from the head down to the toes. Pranabananda Goswami, MD, DMRD, is a Consultant Radiologist at Midnapore Diagnostics Pvt. Ltd. (Kolkata, India). He also serves as Chief Radiologist and Radiology Director at VIP Apex Medical Center (Kolkata) and Chief Radiologist at ESI Hospital (Kolkata). Dr. Goswami received his medical degree and DMRD from the University College of Medicine (Kolkata) and his MBBS from R G Kar Medical College. He has also served as Assistant Professor of Radiology at R G Kar Medical College. www.gehealthcare.com/ct • November 2011 11 C u s t o m e r S p o t l i ght Optima Ct660 in india C U S T O M E R S P O T L I G H T Delivering Quality Care: From Vision to Reality By T. Mukuntharajan, MD, MBBS, DMRD, Head of the Department of Interventional Radiology & Radiodiagnosis; N. Karunakaran, MD, Consultant Radiologist; and R. Ganesh, MD, Consultant Radiologist, Meenakshi Mission Hospital and Research Centre In early April 2011, Meenakhi Mission Hospital and Research Centre (MMHRC) acquired the first Optima CT660 in South India. Our radiology department is recognized as one of the best in the region, providing various sub-specialties such as interventional radiology in conjunction with a fully equipped and advanced diagnostic imaging department. The acquisition of this new CT system will help us manage increasing patient volumes and provide efficient diagnostic support to other specialties. T. Mukuntharajan, MD, MBBS, DMRD 12 A GE Healthcare CT publication • www.ctclarity.com The key benefit for our patients is the system’s exceptional performance at low dose levels. Optima Ct660 in india customer spotlight Case 1. CT Coronary study was performed with retrospective gated acquisition; the volume-rendered images and vessel tree projection show normal epicardial vessels. In the first 72 hours after installation and calibration of the system at our hospital, we conducted more than 100 patient exams. The Optima CT660 system is the latest generation of multidetector CT from GE Healthcare. This new CT system provides a streamlined workflow that assists our radiologists and technologists in efficiently managing the heavy patient workflow. Plus, the Optima CT660 is a GE ecomagination and healthymagination validated product. The environment-friendly power-save mode makes the system more energy efficient with an average electric consumption of up to 60% less compared to previous GE CT systems. A key benefit for our patients is the exceptional performance of the Optima CT660 at optimized radiation dose levels, including generating high-quality diagnostic images with sub-millimeter resolution and enabling high performance with innovations such as backlit diode and high-density interconnects. Specialized dose reduction techniques, such as Adaptive Statistical Iterative Reconstruction (ASiR) and SnapShot Pulse (adaptive prospective cardiac gating), may reduce patient dose for scans including cardiac studies.** In the first 72 hours after installation and calibration of the system at our hospital, we conducted more than 100 patient exams. This included a myriad of routine and advanced patient studies including: coronary angiograms; CABG evaluations; aorotograms; renal angiograms; multiphasic; and perfusion studies. This system scans at a high pitch with a table speed of 110 mm/s in the 0.625 mm detector configuration. One of our initial cardiac studies was on a patient with a BMI of 30.4 (see case 1). Generally, to achieve adequate image quality and offset the increased attenuation due to higher tissue mass, this patient would need to be scanned at higher mAs, leading to a higher radiation dose. However, with the Optima CT660, we acquired the coronary study in 5.1 sec with a retrospectively gated cardiac acquisition technique using ECG modulation at 100 kV. The mA range was 100 to 300, with peak mA for mid-diastolic phase. The total dose for the coronary acquisition was 3.85 mSv (DLP 275.03 mGy cm, conversion factor ICRP 0.014*DLP). ** In clinical practice, the use of ASiR and SnapShot Pulse may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. www.gehealthcare.com/ct • November 2011 13 C u s t o m e r S p o t l i ght Optima Ct660 in india C US T OM E R SPO T LI G H T Case 2. Abdominal angiography with suspected SMA ischemia. 3D volume-rendered image (far right) after one click Autobone Xpress* for removing bones. The VR IVUS ‘like’ view shows atheromatous mixed plaques along the lower aorta–iliac vessels. Another interesting case is an abdominal angiography for a patient who presented with suspected SMA ischemia (see case 2). This study was also performed at very low mAs—with a maximum of 58.8 mA. (The scan technique helical mode was at 120 kV, 98 mA, 0.6 sec, pitch factor 1.375:1). Angiographic and routine images from the same data demonstrate excellent image quality even at a low mA. The total dose for the study was 2.8 mSv, which is 70% less than the ICRP stated “nominal” dose of 10 to 20 mSv (ICRP Publication 87, Managing Patient Dose in Computed Tomography 30[4] Annals of ICRP 2002 [Obtained by EUR-16262 EN Abdomen and Pelvis factor of 0.017 x DLP.]). The Volara XT* DAS system, a component of the Optima CT660, provides a very high signal output at low photon levels. The heavy attenuation produced by the metal hardware in the patient does not result in severe photon starvation effect and artifact from dense hardware (see case 3). (Total dose of 6.3 mSv. DLP 422.96 mGy.cm. Obtained by EUR-16262 EN Abdomen and Pelvis factor of 0.017 x DLP.) The Optima CT660 also plays a very important role in our ability to offer low-dose scanning, which is particularly important for pediatric imaging. It includes GE’s pediatric color-coded protocols, the use of 80 and 100 kV settings, and most importantly, the effective utilization of high-yield performance of the detector at low mA levels. Together, these features make this system an appropriate CT imaging solution for pediatric studies. Case 3. Axial images from a patient scan post laminectomy status with metal screws in situ—the adjacent bones close to the screws are well visualized without any beam hardening artifact or blooming. 14 A GE Healthcare CT publication • www.ctclarity.com Optima Ct660 in india customer spotlight Case 4. Axial images for brain with excellent grey white differentiation. 3D VR and Curved MPR for optic nerves are obtained from the same low dose scans. One pediatric case involved an eight-day-old baby who suffered a head trauma (see case 4). The patient was not opening their left eye after the trauma and a CT of the head was ordered for a detailed evaluation. The exam included a whole brain scan from the floor of orbits with a low-dose technique and total reported dose of 0.83 mSv (DLP 75.83, ICRP conversion factor of 0.011 *DLP for ‘zero’ age group), 80 kV, 120 mA, 1 sec axial mode, and detector configuration 0.625 X 32. The study revealed no traumatic injury or bleed in the brain. To summarize, after our initial experience scanning 100 patients in three days, we found the Optima CT660 exhibited tremendous capabilities in routine and complex studies and provided exceptional image quality at optimized doses. We think the Optima CT660 is an ideal CT scanner for virtually any radiology department seeking eco-friendly, low power consumption, patient comfort, fast workflow, and low-dose scanning capability while delivering quality diagnostic images. n T. Mukuntharajan, MBBS, DMRD, is Head of the Department of Interventional Radiology & Radiodiagnosis, Meenakshi Mission Hospital and Research Center (Maduria, Tamilnadu, India). He received his MBBS and DMRD from Madurai Medical College. He specializes in vascular and interventional CT imaging, endoscopic ultrasound, echocardiography, and vascular and non-vascular interventional radiology procedures. With over 700 beds, Meenakshi Mission Hospital & Research Centre (S.R. Trust ) has grown to be a multi-specialty hospital, touching lives in and around Madurai. The hospital extends the traditional Indian hospitality to international patients, combining it with cutting edge technology, clinical excellence, and compassion to deliver quality healthcare to all patients. S.R. Trust is a non-profit organization registered under the Indian Trust Act (May 9, 1985). www.gehealthcare.com/ct • November 2011 15 C u s t o m e r S p o t l i ght B r i v o C T 3 2 5 i n ch i n a C U S T O M E R S P O T L I G H T Seeing Beyond the Naked Eye By Dr. Yang Shenghong, Director of Radiology, Yichun Yuanzhou Red Cross Hospital Yichun Yuanzhou Red Cross Hospital is a 318-bed, private, Tier-2 hospital—a mediumsized hospital often referred to as a district, or township hospital. With more than 250 medical staff in the hospital and varied specialties in the facility, Yichun Yuanzhou Red Cross Hospital is considered one of the larger and more advanced medical facilities in Yichun Prefecture-level city.‡ In April 2011, Yichun Yuanzhou Red Cross Hospital installed its very first CT system—the Brivo§ CT325. Dr. Yang Shenghong Clinically, we are impressed that the system is easy to use yet doesn’t compromise image quality. ‡ A prefecture-level city is an administrative unit that typically comprises a main central urban area (often with the same name as the prefectural level city) and its much larger surrounding rural area containing many smaller cities, towns, and villages. The larger prefectural level cities can be over 100 km across in size. Prefectural level cities nearly always contain multiple counties, county level cities, and other such sub-divisions. (Source: Wikipedia) § Brivo CT325 is not for sale in the United States. Not cleared by the US FDA. 16 A GE Healthcare CT publication • www.ctclarity.com B r i v o CT 3 2 5 i n c h i n a customer spotlight Ankle reconstruction Lumbar reconstruction When we began our search for a CT scanner, GE was a natural choice for our hospital and five radiologists. We already have GE X-ray, fluoroscopy, and ultrasound systems, and our experience with these other systems has been very good. So when we selected the Brivo CT325, we knew without question that it would be a fine, quality system. After seven months of using the new CT system, we have realized many benefits for our patients and clinicians. Clinically, we are impressed that the system is easy to use yet doesn’t compromise image quality. We have found the Brivo CT325 has excellent image quality in terms of low contrast resolution and detectability, especially when compared to CT systems in this segment that we’ve used at other hospitals. The digital tilt feature can produce reconstructed images through helical scanning, reduce scan time, and optimize CT study workflow. Digital Tilt (DT) is an image reconstruction method on CT systems that do not have gantry tilt capability. Reformatting to obtain 2D/3D images with a helical scan is also possible for certain anatomy such as the sinus or nasal bone. Yichun Yuanzhou Red Cross Hospital www.gehealthcare.com/ct • November 2011 17 C u s t o m e r S p o t l i ght B r i v o C T 3 2 5 i n ch i n a C U S T O M E R S P O T L I G H T Head reconstruction Chest reconstruction For radiologists, design and ergonomics complement the system’s imaging capabilities. Thanks to a more efficient workflow, lumbar spine scanning is more streamlined compared to other CT systems we’ve used. With thin-slice imaging, we can better visualize anatomy, especially the sinus. This was not attainable with other CT scanners in this segment that we’ve encountered. Currently, we conduct approximately 15 CT studies each day. These CT scanning procedures have been well-received by residents of the city, who have reported having positive CT scan experiences. This is good news, given that we expect patient volume to double within the next 12 months. While today there are seven Brivo CT325 systems in the Jiangxi Province, we are proud to be one of the first installed sites. n Thanks to a more efficient workflow, lumbar spine scanning is more streamlined compared to other CT systems we’ve used. Dr. Yang Shenghong is Head of the Department of Radiology and has more than 15 years of experience in his field. Yichun Yuanzhou Red Cross Hospital in Yi Chun city, Yuanzhou district is located in the northwest of Jiangxi Province. In ancient times, Yuanzhou was known for its education, made famous by Han Yu, a renowned poet in the Tang Dynasty. Yuanzhou lies in Yichun Prefecture-level city and Yichun literally means “Pleasant Spring.” 18 A GE Healthcare CT publication • www.ctclarity.com cardiac imaging clinical value Meeting the Clinical Need for Low-dose Cardiac Studies In December 2010, Clinic “La Reine Blanche” Orléans-France installed an Optima CT660 with ASiR. In explaining the reason to select the Optima CT660, Olivier Genée, MD, cardiologist, says, “The Optima CT660 fulfilled our requirement for a 40 mm wide detector.” Another very important consideration for the facility is the issue of patient radiation dose, he adds. With ASiR, the clinicians may prescribe low-dose CCTA exams. Predicting CCTA volume is a difficult task, yet the clinic believed that a scanner with advanced CTA imaging capabilities and low dose would increase patient and referring physician demand. Therefore, the total cost of ownership— including a smaller footprint that can reduce siting costs and lower energy consumption—was also an important factor in the facility’s final decision. After a thorough review of available solutions and weighing the site’s requirements, Dr. Genée and his team found the Optima CT660 best met their needs for an advanced imaging system with low dose capabilities—and lower operating costs. Installation of the Optima CT660 has modified the diagnostic path in the clinic. For example, the clinic often requires a CCTA after an inconclusive scintigraph scan from a gamma camera before the patient undergoes a therapeutic angiography in the cath lab. Interestingly, as the volume of cath lab procedures increased, so too did the CCTA exams. A B C D Figure 1. Myxome of the left atrium as seen in a retrospectively gated acquisition. A B Figure 2. The vessel lumen is clearly seen as the calcium blooming is significantly reduced. www.gehealthcare.com/ct • November 2011 19 c l i n i ca l v a l u e ca r d i ac i m ag i n g B A C D Figure 3. Approximately 50% stenosis seen in the RCA. Dr. Genée says that the CCTA rules out false positives that often appear during stress tests and supports treatment decisions regarding coronary conditions. When the CCTA test indicates a low probability of CAD, the patient can avoid a diagnostic cath lab procedure. According to the clinic’s practice, patient selection is determined with the help of a medical prescriber. If the patient’s heart rate is over 65 bpm, the clinic uses betablockers prior to the CCTA. Dr. Genée finds that performing CCTA in an emergency setting may be difficult due to patient arrhythmia or even fibrillation. The team finds the post processing is very flexible and powerful. Additionally, the Optima CT660 has allowed Clinic “La Reine Blanche” Orléans-France to perform new types of cardiac CT studies, further broadening its clinical expertise. The clinic conducts examinations of myocardium function in patients with certain non-echogenic tumors or inaccessible trans-esophageal ultrasound. Vascular CT exams allow for accurate diagnosis in cases of aorta dissection when trans‑esophageal ultrasound is not sufficient. Finally, after the Optima CT660 installation, patients with an indication of pulmonary embolism can now be examined on site without transferring them to another hospital. Asked what he would say to a colleague considering implementing an Optima CT660, Dr. Genée says, “We are very satisfied with the Optima CT660 with ASiR. It meets our expectations and offers an excellent quality-to-investment ratio.” n Olivier Genée, MD, is a cardiologist at the Unité Cardiologique de la Reine Blanche (Orléans, France). He is also a specialist in emergency medicine. Dr. Genée received his initial medical training at the University of Lille, and worked in the cardiac intensive care unit of the University Hospital Center of Tours. He is an expert in treatments and non-invasive cardiac explorations, including transthoracic echocardiography, cardiac CT, and MRI. Dr. Genée is an associate member of the French Society of Cardiology, and a member of the French Society of Emergency Physicians. He is also a researcher and has authored several articles and publications in cardiology and emergency medicine. Clinic “La Reine Blanche” Orléans-France is a medium-sized hospital of more than 200 beds. Since the clinic opened in 1970, its primary focus is cardiology and pathologies linked to cardiovascular such as diabetes, endocrinal disease, and kidney failure. The medical recruitment involves at least 20 cardiac CT Angiography (CCTA) exams each week. The clinic also has a follow-up care mission in cardiac, nutrition, and post pathologies recovery. Currently the Cardiology Department provides services to the Loiret and Romorantin-Lanthenay region. In 2013, the clinic plans to merge healthcare services to a new facility with two other institutions from Orléans: Polyclinic des Longues Allées and the Radiotherapy center COROM. This new clinic will have approximately 500 beds and offer all surgery activities, along with cardiovascular services, to the residents North of Orléans city. 20 A GE Healthcare CT publication • www.ctclarity.com VE O : ULT R A - L O W D O S E clinical value Implementing Ultra-low Dose CT with Veo at University Hospital, Brussels Considerations for workflow and patient selection By Professor Johan de Mey, MD, PhD, Chair of Radiology, University Hospital, Brussels University Hospital, Brussels has been using Veo since March 2011. In addition to ultra-low dose CT imaging—in some instances as low as plain film radiography—Veo provides new possibilities for the radiologist to tailor the scan parameters to the patient. For example, radiologists for years have known that when looking for a pulmonary embolism, the exam is tailored to the indication by administering a faster rate of contrast and scanning the bolus earlier. If the clinician is investigating the possibility of interstitial disease in the lungs, then the radiologist would perform the CT scan at a higher resolution and thinner slices. These examples, while part of the typical radiology practice, demonstrate the versatility of CT imaging that we have fine-tuned over the course of 20 years. With Veo in our facility, we have further expanded CT imaging into clinical possibilities. We have achieved reduced mA and kV in the acquisition of diagnostic images and thereby been able to reduce dose to previously unthinkable levels.** ** In clinical practice, the use of Veo may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. Enabled with Veo, these new possibilities can be further tailored to the patient by adjusting CT parameters radiologists have used for decades. In fact, Veo has opened up new possibilities for challenging cases and sensitive patients. For example, while Veo may allow scans at an ultra-low dose, we can still scan at typical dose levels and obtain images with higher spatial resolution and better delineation of structures. The key to the successful implementation of these new scanning possibilities is determining the appropriate patient group that will benefit most from the Veo technology and understanding how it can be used without impacting radiology workflow. Workflow Veo is a processing technique that generally requires more time (estimated from 20 to 80 minutes) to generate a high-quality image from an ultra-low dose acquisition. In our facility, this has not presented any issues to our radiology workflow. As in most www.gehealthcare.com/ct • November 2011 21 c l i n i ca l v a l u e V E O : ULT R A - L O W D O S E Veo provides new possibilities for the radiologist to tailor the scan parameters to the patient. Professor Johan de Mey public hospitals across Europe and the US, radiologists perform their interpretations and reporting in a reading room or back office, well after the exam has been completed, and not in the CT room or while the patient is in the scanner. In our facility, the need for an immediate diagnosis occurs in approximately 5% of our patients—i.e., emergency cases—and, therefore, we use ASiR for low-dose CT studies in these instances. However, even in emergency cases the physician must often wait 30 minutes for laboratory results, so we believe the additional time to utilize Veo is not an issue considering other test results will require time for analysis. For the technologist, workflow efficiency is also not compromised. Even with an ultra-low dose scan, the CT scanner immediately provides images so the technologists can evaluate that the proper patient positioning was attained for displaying the anatomy or pathology in question. Our technologist can determine from the initial images that the exam acquired the desired anatomy. A B Patient selection A critical component to maintaining an efficient workflow using Veo is identifying patients who would benefit most from an ultra-low dose exam. Because we only have one Veo (box) at our facility, we cannot utilize it on each patient receiving a CT scan. As mentioned above, emergency cases should be evaluated based on other dose lowering techniques available (e.g., ASiR). Radiotherapy patients are also often excluded as the amount of radiation dose from CT is small compared to the treatment they received. Although we continue to adapt the patient criteria for Veo reconstructions, our facility has identified the following patient groups, who may benefit most from a Veo scan: pediatric patients, particularly those who require regular scanning and follow-up due to a disease or affliction, young adults, adults with a disease requiring regular X-ray or CT imaging follow-up, and adults with kidney disease. C Figure 1. A two-year-old patient with empyema. Exam conducted at DLP 27 mGy.cm with an effective dose of 0.9 mSv (Obtained by EUR-16262 EN, using a pediatric chest factor of 0.031*DLP). Acquisition parameters are 80 kV and 15 mAs. 22 A GE Healthcare CT publication • www.ctclarity.com VE O : ULT R A - L O W D O S E A B clinical value C Figure 2. Maxillofacial CT of a nine-year-old patient with a fracture of the inferior orbita. Exam conducted at DLP 38.97 mGy.cm with an effective dose of 0.31 mSv (Obtained by EUR-16262 EN, using a pediatric head factor of 0.008*DLP). Acquisition parameters are 100 kV and 14 mAs. Historically in our facility, pediatric patients with cystic fibrosis and no health complaints received a lung X-ray every two years. This was the first pediatric group for which we utilized the Veo reconstruction. In most cases, the patients are stable, and some have previously identified lung lesions. We initiated a doubleblind study, substituting the X-ray with low-dose CT performed at the same dose level as the X-ray. We noticed we could see more anatomy with the volume CT than the prior X-ray. There were cases where the CT demonstrated an evolution in pathology that was previously deemed stable based on the X-ray data. CT provided the ability to detect lesions more clearly, which in many instances will impact patient treatment. We ultimately moved all cystic fibrosis pediatric patients to Veo low-dose CT follow-up. Young adults are another category where the benefit from ultra-low dose CT is great. As with pediatrics, the patient’s history and indications are reviewed to determine the best imaging option and appropriate low-dose reduction. Another group of patients who receive low-dose Veo CT scans at University Hospital are those suffering from Crohn’s Disease. These patients often have complaints related to this bowel disease and receive CT exams. Lastly, for patients with kidney disease we have adjusted our protocols to lower kVs to help us address iodine use in patients who may be sensitive to it. Based on our experience, developing the proper Veo protocols— both in patient selection and implementing low-dose imaging—is important for successful implementation. As one of the first sites to clinically use Veo, we continue to examine Veo’s potential and implementation on specific patient groups. One thing we learned is that we cannot uniformly lower dose for every indication when changing the protocols. For each patient group, we are still building our experience and determining the appropriate dose levels. Additional scientific studies, including the global multi-site clinical study that GE is sponsoring, will provide additional information to help optimize dose level protocols for each patient group. n Editor’s note: For more information on the global multi-site clinical study, please see article on page 54. » www.gehealthcare.com/LowerDoseByDesign Johan de Mey, MD, PhD, is Chair of the Radiology Department at University Hospital, Brussels, and a Professor at Brussels University where he is also the coordinator for radiology resident training. Prof. de Mey earned both doctorate degrees at the Vrije Universiteit Brussels; his PhD thesis was CT fluoroscopy in interventional radiology. As Professor, he lectures on radiology anatomy, normal and pathologic radiology and emergency radiology. Located in the heart of Europe, the University Hospital Brussels is one of Belgium’s premier centers of excellence in healthcare, biomedical research and medical education. One of seven University Hospitals in Belgium, it is closely associated with the Brussels University. University Hospital Brussels has gained recognition at both a national and an international level. With its 700 beds and staff of 3,000, close to 30,000 inpatients and 500,000 outpatients are treated every year. www.gehealthcare.com/ct • November 2011 23 c l i n i ca l v a l u e B r i ght S p ee d E l i te w i th I Q E N H A N C E BrightSpeed Elite with IQ Enhance Delivers Speed and Clarity in the Carolinas Carolinas Imaging Service (CIS) is a joint venture between Charlotte Radiology and Carolinas HealthCare System located in metropolitan Charlotte, NC. The group provides patients with a freestanding, outpatient option across a multitude of imaging systems and exam types. The one thing Dr. Coumas loves about CT in general is the speed. “A patient comes in with pain that is non-specific and CT is used as a rule-out mechanism for the pain,” he explains. “The advantage of CT is it takes two minutes; MR is 30 to 45 minutes. When you are in pain, this is a long time to be on a table for a scan.” In November, 2010, CIS decided to outfit its outpatient imaging clinic in South Park with a BrightSpeed Elite CT. One clinical area where the new system has made an impressive impact is in musculoskeletal (MSK) imaging. Currently, between 15 to 20 MSK CT studies are performed each day at CIS. Dr. Coumas is particularly excited about the BrightSpeed Elite and the IQ Enhance (IQE) feature. IQE allows the group to use their 16-slice scanner with faster pitch helical scanning at a similar artifact index level compared to slower helical scanning without IQE. This coverage speed is equivalent to that of wider detectors (50 slice equivalent) at the same table speed. This decreases the length of time per study without a corresponding loss in image quality, he explains. In fact, Dr. Coumas prefers using the IQE feature on all MSK cases. When it comes to MSK, James Coumas, MD, knows bones. He graduated with a fellowship in musculoskeletal radiology from Massachusetts General Hospital and reads MSK images full time. “With 85 radiologists in our group, we have the ability to specialize into specific regions of the body that interest us. For me, that is the musculoskeletal system.” Dr. Coumas is passionate about the work he does in MSK. “Musculoskeletal radiology spans a spectrum of disease processes as well as congenital and acquired abnormalities,” he says. “Whether it’s a congenital anomaly, a response to a debilitating disease process, an acute sports injury, or aged encumbered degenerative arthritis, the musculoskeletal system is usually involved.” He also does a great deal of referral work with orthopedic surgeons who have had issues with certain implant recalls. “Artifact reduction in prosthetic imaging is a large part of our business with patients 40 to 60 years of age. It is important to have a scan that you are able to see 360° around the prosthesis to determine if there is anything loose, fractured, or dislocated (Figure 1).” Dr. Coumas is enthusiastic about using the BrightSpeed Elite for his patient cases. “We have 15 scanners in our group and for MSK workups we currently send all our patients to the BrightSpeed.” “A patient comes in with pain that is non-specific and CT is used as a rule-out mechanism for the pain. The advantage of CT is it takes two minutes; MR is 30 to 45 minutes. When you are in pain, this is a long time to be on a table for a scan.” Dr. James Coumas 24 A GE Healthcare CT publication • www.ctclarity.com B r i g h t S p e e d E l i t e w i t h I Q E N HA N CE A clinical value B Acquisition Protocols: kV: 120 mAs: 191-310 Pitch: 1.375:1 Coverage: 116 mm Scan time: 6.69 sec Figure 1. (A) Volume-rendered image; (B) sagittal view image Patient case with and without IQE A 68-year-old male patient presented at CIS with a history of mild chronic obstructive pulmonary disease (COPD). A chest CT exam with contrast revealed a new right apical cavity nodule. The comparison images (Figure 2) demonstrate how A the BrightSpeed Elite with IQE can help to reduce the amount of streaking and windmill artifact in the coronal dataset. Overall, the BrightSpeed Elite has been a positive decision for CIS. It’s intelligent, versatile, and user-friendly. Dr. Coumas sums it up best, “For routine body work, the Brightspeed Elite is all I need.” n B Acquisition Protocols: kV: 120 mAs: 276-436 Slice thickness: 0.625 Coverage: 336 cm Pitch: 1.75 Figure 2. (A) With IQE and (B) without IQE. James M. Coumas, MD, specializes in musculoskeletal radiology at Carolinas Imaging Services. He earned his medical degree and completed his residency at the University of Massachusetts Medical School (Worchester) and a fellowship in musculoskeletal radiology at Massachusetts General Hospital. Charlotte Radiology (CR) is one of the largest and most progressive radiology groups in the nation, serving Mecklenburg and surrounding counties since 1967. With 80+ radiologists with diverse and specialty training—including Mammography, Musculoskeletal, Pediatrics, and Interventional Radiology— CR provides 24/7 coverage for more than 11 hospitals and four outpatient imaging centers (including CIS). In addition to CIS, the group owns and operates 12 breast centers, two vascular and interventional clinics, and an MRI center. www.gehealthcare.com/ct • November 2011 25 c l i n i ca l v a l u e B r i ght S p ee d E l i te w i th I Q E N H A N C E IQE helps to minimize aliasing of the signal Helical windmill artifact is caused by the aliasing of the signal. Aliasing occurs when a signal is sampled too slowly or at a frequency comparable to or smaller than the signal being measured and, as a result, obtains an incorrect frequency and/or amplitude. The following case is a great example of how the windmill helical artifact surrounding bone can be minimized to enhance the final outcome by scanning with IQE at a pitch of 1.75. This scan, done in 5.4 seconds, demonstrates the excellent spatial resolution as well as speed using BrightSpeed Elite with IQE. The IQE algorithm dynamically detects the presence of aliasing and automatically corrects for such artifact. Helical Artifact Index is defined as: ((SD value at ROI1)2-(SD value at ROI2)2)1/2. Two helical data sets were acquired to compute a Helical Artifact Index. n A Acquisition Protocol: B Scan type: Helical (IQE) kV: 120 mAs: 90-210 Pitch: 1.75 Coverage: 70 mm/s Scan time: 5.4 sec Gantry rotation: 0.8 sec Slice thickness: 1.25 mm SFOV: large DFOV: 32 cm Start/End: S200-I370 Reconstruction: 512 matrix One data set was acquired at 1.75:1 pitch with table speed of 37.5 mm per rotation with IQE ON at 260 am and other using 0.562:1 pitch with table speed of 11.25 mm per rotation with IQE OFF at 160 mA. Figure 3. (A) With IQE and (B) without IQE 26 A GE Healthcare CT publication • www.ctclarity.com m u s c u l o s k e l e ta l i m a g i n g clinical value Emerging Applications in Musculoskeletal CT Imaging By K Murali MD(RD), PDCC, Director of Interventional Radiology, G. Francis DMRD, DNB (RD), Consultant Radiologist, and R. Madan, MBBS, MD, Consultant Radiologist, MIOT Hospital; Sundar RK, Clinical Applications Manager, CT, GE Healthcare With the recent advances in technology and software development, the utilization of CT in musculoskeletal (MSK) clinical imaging has undergone tremendous improvements. The most observable changes are the availability of High Definition (HD) CT data acquisition and reconstruction, Gemstone Spectral Imaging (GSI) with monochromatic data, effective metal artifact suppression, and dynamic 4D evaluation of joints and tendons using volume helical shuttle. In this article, we share some of our early experiences with the new Discovery CT750 HD installed at our hospital. A HD Imaging The HD scanner can acquire 2.5 times more views per rotation than a typical (non-HD) CT scanner. This results in improved spatial resolution. The images below are acquired with a high definition protocol where both HD standard and HD bone images are reconstructed for analysis for soft tissue as well as for pathologies involving bone and joints (Figure 1). Comparative images of normal routine bone reconstruction and HD scan and reconstruction (Figure 2) show improved spatial resolution with higher bone details in the HD bone images. B Figure 1. (A) HD standard; (B) HD bone www.gehealthcare.com/ct • November 2011 27 c l i n i ca l v a l u e m u s c u l o s k e l eta l i m ag i n g A B Figure 2. (A) Routine bone; (B) HD bone A B Figure 3. (A) HD standard; (B) HD bone The HD images clearly demonstrate the comminuted fracture of calcaneus involving the posterior sub-talar joint. The visualization of cortical margins and trabecular pattern is clearly seen in the HD bone image. The spatial resolution of HD images can be up to 230 microns (calculated using 0% MTF). 28 A GE Healthcare CT publication • www.ctclarity.com Using HD imaging in a knee study, we were able to appreciate subtle findings such as a hair-line fracture of the patella in the HD bone image and other soft tissue details in the HD standard images (Figure 3). m u s c u l o s k e l e ta l i m a g i n g Gemstone Spectral Imaging in implant studies We use dual energy acquisition with fast kV switching enabled by the Gemstone Detector in many of our studies on patients with orthopedic implants. The results were unparalleled and promising. With the GSI technique, we created monochromatic images specific for bone and implants. The projection data based reconstruction technique with metal artifact reduction software (MARs) helps significantly in the reduction of artifacts from high density metal implants and allows the accurate visualization of the underlying bone and adjacent soft tissue. A clinical value The 100 keV monochromatic image with MARs was able to show the implosion of implant into the joint space and producing pressure erosion of the articular surface of femoral condyle. The GSI monochromatic technique with MARs is highly useful in external fixators. Unlike internal fixators, imaging with external fixators involves more challenging issues due to an increase in beam-hardening artifacts that are primarily due to the air gap that exists between the body and the external fixator. We were able to use GSI with MARs to resolve this complex situation (Figure 6). B C Figure 4. (A) A routine reconstruction at 140 kV from a GSI scan data shows significant beam hardening artifact from the implant hardware. (B) Monochromatic image generated from the same GSI acquisition at 100 keV demonstrates the subtle reduction of metal beam hardening artifact without significant difference. (C) The same image reconstructed with MARs in which artifacts were completely removed and we were able to assess the implant integrity and adjacent tissue as well. A B Figure 5. (A) 140 kV; (B) 100 keV with MARs www.gehealthcare.com/ct • November 2011 29 c l i n i ca l v a l u e m u s c u l o s k e l eta l i m ag i n g CT is often used to rule out vascular injuries in pre-surgical and post-surgical orthopedic patients. GSI with MARs helps us diagnose the presence of vascular injury in these complex cases with a high degree of confidence. A B Figure 7 demonstrates the efficacy of MARs in studies involving external fixators by removing beam-hardening effects from the hardware. The 70 keV MARs images show the tibia and the tibial condyles. The margins and cortex of tibial condyle is well visualized compared to the 140 kV standard. Figure 6. (A) 140 kV; (B) 70 keV with MARs A B C Figure 7. (A) Upper limb angiogram for vascular assessment post external fixation of humerus fracture. Note the extensive beam-hardening artifacts from the metal implants obscuring the visualization of the brachial artery. (B) and (C) illustrate 70 keV monochromatic 3D MIP and 3D VR transparency images depicting the normal patent vessel. Figure 8. These images show dynamic sequences of the ankle joint from flexion phase to extension phase. This demonstrates movement of the non-united fracture fragment and focal reduction in posterior sub-talar joint space with apposition of the talus and calcaneus. 30 A GE Healthcare CT publication • www.ctclarity.com m u s c u l o s k e l e ta l i m a g i n g clinical value Figure 9. The coronal phased images reveal the movement of large fracture fragment in to the joint space. Figure 10. The axial KCT images from flexion phase to the extension phase show the subluxation of patella. Kinematic studies in musculoskeletal imaging Kinematic evaluation of the joints involves the use of the Volume Helical Shuttle (VHS) mode of image acquisition. A special reconstruction algorithm—dynamic pitch reconstruction—is used to help prevent artifacts due to movement. In our facility, we have performed kinematic evaluation of studies for joints including the elbow, wrist, knee, and ankle. Kinematic CT (KCT) is highly useful in evaluating movement of loose bodies into the joint space for assessing instability and predicting development of arthritis. K. Murali, MD, is the Director of Interventional Radiology at MIOT Hospitals Chennai practicing diagnostic and interventional radiology. He received his M.B.B.S. Coimbatore Medical College (City), medical degree from Gujarat University (City), and post-doctoral certificate in neuro and vascular. Dr. Murali has published twelve scientific articles, a text book chapter, and presented numerous scientific papers in national and international conferences. With the advent of technological developments in CT such as GSI, MARs, and HD, we are able to overcome previous limitations in MSK CT imaging. The use of VHS in orthopedic studies has resulted in the dynamic evaluation of joints. We have used these new techniques very effectively in the evaluation of MSK pathologies with a high degree of diagnostic confidence and accuracy. n G. Francis, MD, is a senior consultant radiologist at MIOT Hospitals Chennai specializing in MSK and vascular CT. He received his M.B.B.S. from Christian Medical College (Vellore), his D.M.R.D. from Stanley Medical College (Chennai), and his D.N.B. (radio diagnosis) BIR from Madras Medical College (Chennai). R. Madan, MBBS, MD, is a Consultant Radiologist at MIOT Hospitals. Dr. Madan received his medical degree from the Government Medical College, Madurai, and his MBBS from Stanley Medical College. He spent three years as a senior resident at Sanjay Gandhi Post Graduate Institute of Medical Sciences. Dr. Madan’s areas of interest are musculoskeletal radiology and image-guided biopsy. MIOT Hospitals Chennai is a 500-bed, multi-specialty hospital in India founded by a physician. The hospital is recognized as a leading center known for orthopedics and orthopedic research, including joint replacement surgery with 35,000 successful hip and knee replacement and revision surgeries. It is also the first hospital in the Asia-Pacific region and second hospital in the world to have a computer-integrated navigation system for joint replacement surgery. MIOT also has specialized centers for: nephrology, including the largest and most modern nephrology department in the country—performing five renal transplants each month and, in collaboration with Japan, kidney transplants across blood-type groups—and a state-of-the-art dialysis unit; thoracic and cardiovascular care offering endovascular grafting for aortic aneurysm by keyhole surgery procedures and beating heart surgery; neurology and neurosurgery; and pediatric cardiac surgery for treating congenital heart disorders. www.gehealthcare.com/ct • November 2011 31 c l i n i ca l v a l u e 4D oncology 4D CT With Respiratory Gating Helps Locate and Track Lesions to Reduce Target Volumes By Xiaodong He, MD, Radiotherapy and Thermotherapy Center, Shanghai Pulmonary Hospital In order to improve accuracy in radiation therapy for chest and abdomen cancers, it is necessary to visualize, control, and track patient specific respiratory motion. Tumors near or around the diaphragm will likely move with respiration. the treatment field resulting in an under dose to the target. Some techniques such as breath-holding, forced shallow breathing, and respiratory-gated treatment techniques have been implemented to account for respiratory motion. Without the means to limit respiration-induced target or organ motion, large treatment fields have to be used, potentially resulting in more irradiation of surrounding normal tissues. As a result, the risk of complications may increase. Conversely, if smaller treatment fields are used, the target may move out of Therefore, precise targeting of the tumor and tracking of respiratory motion are important to patient outcomes. A Since October 2009, we have used Varian’s Real-time Position Management™ (RPM) System, which uses an infrared tracking camera and reflective marker to measure the patient’s B Figure 1. (A) Illustrates lesion location in inspiration; (B) shows lesion location in expiration, demonstrating the movement of the lesion during the respiratory cycle. Real-time Position Management (RPM) System is a trademark of Varian Medical Systems, Inc. 32 A GE Healthcare CT publication • www.ctclarity.com 4D oncology clinical value We are able to deliver effective patient treatment with customized treatment plans based on each patient’s respiratory cycle. Dr. Xiaodong He respiratory pattern and extent of motion. Advantage 4D*, a respiratory motion management application on the Advantage Workstation, helps providers analyze respiration-induced motion of anatomy based on data acquired using the Varian RPM in conjunction with the GE RT CT system. Prior to treatment planning, patient CT images are acquired and processed in 4D. The patient is scanned using a Cine CT respiratory protocol and the respiratory waveform file is simultaneously recorded with an external respiratory gating system, e.g., RPM. The Advantage 4D software then sorts and saves the Cine CT image data into phases and intensity projections (MIP, Average, Min-IP). In our facility, we are using the 4D data and RPM on approximately 10% of patients—those who have stable and reproducible breathing. We have found that 4D CT data aids in assessing the tumor location. Using the GE Advantage 4D with the Varian RPM system has helped us reduce the inner target volumes. The impact on patient treatment since the implementation is impressive. We are able to deliver effective patient treatment with customized treatment plans based on each patient’s respiratory pattern. We are experiencing a decline in acute radiation-induced pneumonia rates, which further increases our confidence in 4D treatment planning and ability to effectively irradiate the lesion and spare more surrounding healthy tissue. n With GE’s Cine acquisition, the CT images of the MIP dataset are utilized in the treatment planning system. We then select the 4D CT phases corresponding to the 30%~70% breathing phases of the patient. » www.gehealthcare.com/aw/applications/ advantage-4d/ Professor He Xiaodong, MD, is the Chief Physicist and Vice Director of the Radiation Oncology Department at Shanghai Pulmonary Hospital. His research of radiophysics, radiobiology, and thermotherapy includes dosage study on EPID; X-ray beam dose distribution reconstruction; electron beam dose calculating model; enlargement of volume effect in LQ model; bioequivalent DVH (BDVH) calculation; RF thermodosage theorem; and portal image processing technique. He is also well known in China for his expertise on moving target radiation therapy. Shanghai Pulmonary Hospital is affiliated to Shanghai Tongji University (also known as Shanghai Occupational Disease Hospital). The hospital opened in 1933 and the radiation oncology department—dedicated for lung and esophagus cancers and mediastinal and metastatic tumors—was built in 1989. Oncology equipment includes two Linear Accelerators (one with RPM), a set of large aperture 4D CT simulators, one X-ray simulator, and several treatment planning systems. www.gehealthcare.com/ct • November 2011 33 c l i n i ca l v a l u e EMERGENCY RADIOLOGY High-Definition CT Improves Triage and Door-to-treatment Times in Emergency Radiology CT has become an important diagnostic tool for the Emergency Department (ED) physician. A recent study in the Annals of Emergency Medicine found that in the US, approximately one in seven ED patients received a CT scan as part of their evaluation.1,2 The top indications for CT use in the ED are abdominal pain, flank pain, chest pain, shortness of breath, and trauma. The study examined data from the National Hospital Ambulatory Medical Care Survey on nearly 100 million patients receiving a CT scan in the ED between 1996 and 2007. Between 1996 and 2007, CT use during ED visits increased 330%, with the largest increase in patients older than 79 (9.1% in 1996 to 29.1% in 2007). In addition to CT possibly correlating to a reduction in the rate of hospitalization or transfers, the study also found it may impact decisions about where hospitalizations occur, with a shift away from expensive ICU admissions. The following are profiles of two facilities utilizing CT in the ED to positively impact patient outcomes and help clinicians make the most appropriate care decisions. 1.Kocker KE, Meurer WJ, Fazel R, et al. National Trends in Use of Computed Tomography in the Emergency Department. Annals of Emergency Medicine 12 Aug 2011; published online 2.Barnes E. Rise in CT use linked to drop in hospital admissions. AuntMinnie.com. Available at http://www.auntminnie.com/index.aspx?sec=sup&sub=imc&pag=dis&ItemID=96135 34 A GE Healthcare CT publication • www.ctclarity.com Images courtesy of St. Vincent Hospital. However, the study found a correlation between CT use and a drop in hospital admissions. According to one of the authors, Keith Kocher, MD, University of Michigan, the likelihood of hospitalization or transfer after a CT declined throughout the study period, from 26% in 1996 to 12.1% in 2007. The rate leveled off after 2003 despite a continued increase in the adjusted, overall rate. Figure 1. The Discovery CT750 HD scanner installed at St. Vincent Hospital. St. Vincent Hospital At St. Vincent Hospital (Indianapolis, IN), a Discovery CT750 HD is an integral part of the hospital’s ED, Level II Trauma Center, and Stroke Center of Excellence. Since opening the trauma center, ED volumes have increased, says Nikki Duckworth, RT, MBA, Manager of Medical Imaging Services. Today, the 39-bed ED handles an average of 149 patients each day. EMERGENCY RADIOLOGY clinical value “As a Stroke Center of Excellence, the VolumeShuttle technology has helped simplify the protocol and added noticeable improvement to the study by enabling an increase in the area of interest.” Dr. Michael Skulski “For routine cases, the nurse manager alerts us when the patient is ready for CT,” Duckworth explains. “In trauma cases, a mass page goes out with an estimated time of arrival, so the patient goes straight to the CT when stabilized.” replacement patient to the hospital for evaluation. “We could identify a non-union, incomplete fracture proximally to the hip replacement, and I’m not certain we would have identified that without GSI.” For the most severe trauma patients, the CT protocol includes the head, cervical spine, chest, abdomen, and pelvis, says Michael Skulski, MD, Chair of Medical Imaging at St. Vincent. “We want to assess the patient as quickly as possible, and this system is very good from that perspective.” In fact, Corey Graff, RT(CT), CT technologist at St. Vincent, is impressed by the exam split capability on the Discovery CT750 HD. “If I have a trauma patient and don’t have a patient ID, I can scan all the exams in our protocol, one after another, and at the end send all the exams wherever they need to go. I don’t have to re-landmark and that helps with the patient flow.” While it is too early for Dr. Skulski to make any definitive clinical statements on the value of GSI, he’s excited at the potential benefits. “We are still learning the capabilities of GSI and haven’t yet scraped the surface of its impact.” Dr. Skulski adds, “The speed of this system has addressed the issue of patient motion and with ASiR we’ve decreased radiation dose by 30% to 40%.** Reformats are virtually instantaneous, and the trauma surgeons are very impressed with the quality of the images.” Selecting the Discovery CT750 HD was a carefully considered choice. Says Duckworth, “We needed a CT that was fast, could potentially help us lower radiation dose, and handle a variety of exams.” This system provides all of the above and more for St. Vincent. Dr. Skulski is also impressed with the potential he sees with Gemstone Spectral Imaging (GSI)—another key factor in selecting the system. In fact, a physician from another state sought out St. Vincent because of the GSI technology and referred a hip “As a Stroke Center of Excellence, the VolumeShuttle technology has helped simplify the protocol and added noticeable improvement to the study by enabling an increase in the area of interest,” explains Dr. Skulski. Plus, based on outcome data and the desire to reduce door–to-treatment time, the institution has changed its initial neuro/stroke protocol from three studies to one. Stroke patients first receive a non-contrast CT head. After TPA administration and evaluation, if another CT study is ordered the patient then receives a non-contrast CT of the head, a CTA of the head and neck, and CT perfusion—these three studies comprised the original neuro/stroke protocol. “Our goal is to improve door-to-treatment time for these patients so they can begin their anti-coagulation therapy sooner,” explains Dr. Skulski. With the revised CT protocol using the high definition capabilities of the scanner, the CT study has dropped from approximately 15 minutes down to three. Looking back at their system choice, the team at St. Vincent is confident the Discovery CT750 HD will meet their present and future needs. Adds Dr. Skulski, “I’m confident with this scanner we are only at the beginning of exploring new innovations from GE.” ** In clinical practice, the use of ASiR may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. www.gehealthcare.com/ct • November 2011 35 c l i n i ca l v a l u e EMERGENCY RADIOLOGY “By introducing volume image reading in the ED, the workup for a mass casualty patient has decreased from an average of 15 minutes to 8 minutes.” Professor Ulrich Linsenmaier Ludwig-Maximilians University Hospital In the heart of Munich is one of Europe’s leading medical research universities and public health centers. The nearly 1,000-bed University Hospital of the Ludwig-Maximilians University (LMU) is home to one of the largest radiology departments in Europe and chaired by Professor Maximilian Reiser, FACR, FRCR, a world-renowned radiologist. “We’ve seen an increase in patient volume and our ability to handle a series of emergency patients is important, as in mass casualties,” Prof. Linsenmaier says. “Now, with the B Images courtesy of Ludwig-Maximilians University Hospital. A Nearly two years ago, the University Hospital at LMU installed a Discovery CT750 HD in the ED. According to Professor Ulrich Linsenmaier, Vice Chair for Clinical Operations in the Department of Clinical Radiology, it is the most reliable scanner the hospital has ever had in the ED with nearly no unplanned downtime. Figure 2. Low-dose MDCT of the cervical spine; images were obtained on 64-row MDCT standard scanner using FBP (left, DLP of 265.05 mGy-cm) and on the new Discovery CT750 HD scanner using ASiR (right; DLP of 107.36 mGy-cm). 36 A GE Healthcare CT publication • www.ctclarity.com EMERGENCY RADIOLOGY B C Images courtesy of Ludwig-Maximilians University Hospital. A clinical value D E F Figure 3. Whole-body MDCT in different patients after major trauma (polytrauma) obtained on a Discovery CT750 HD scanner using ASiR; images allow for a quick and comprehensive diagnosis of multiple injuries and fractures of the skull, spine, and even complex peripheral injuries involving bony and vascular structures at the same time. Discovery CT750 HD in our ED, we have a faster workflow and prompt access to the imaging data, especially by volume image reading. “By introducing volume image reading in the ED, the workup for a mass casualty patient has decreased from an average of 15 minutes to 8 minutes,” he says. Moreover, the axial, multiplanar, and volume rendered images are readily available, an important factor in ED imaging. “The HD scan mode provides excellent spatial resolution and scanning of large body volumes,” Prof. Linsenmaier explains. “The protocols for major trauma patients include long scan fields, and the X-ray tube performs remarkably well with virtually no cooling problems,” he adds. Reducing patient radiation dose with ASiR is an impressive feature as well. In major trauma cases undergoing whole-body CT, the ED department has decreased dose by nearly 30%, www.gehealthcare.com/ct • November 2011 37 c l i n i ca l v a l u e EMERGENCY RADIOLOGY Prof. Linsenmaier says. Significant dose reduction capabilities will further impact the department’s choice of imaging device, as a CT image can provide more information than digital radiography. Currently, the University Hospital performs clinical low-dose CTs of the C-spine between 0.7 and 1.1 mSv. In addition to lowering dose, the Discovery CT750 HD is further impacting the quality of patient care through new capabilities. Specifically, larger perfusion volumes along with CT angiography and temporal subtraction imaging (TSI) are used for diagnosing stroke and pulmonary embolisms (PE). With these imaging tools, the University Hospital now uses CT in place of MRI diffusion imaging. “Our protocol combines native CCT and CTA of the supra aortic vessels with a perfusion scan of the cerebrum,” explains Prof. Linsenmaier. An additional advantage of using CT for these patients is the availability of the scanner 24/7 with direct access in the ED. “Monitoring the patient is easier and we don’t have to transfer them out of the ED,” he adds. “We can work up the patient in one robust exam—this is an entirely new way for us to handle stroke and PE patients.” While the potential for reducing dose in complex cases most impresses Prof. Linsenmaier, he also recommends that other hospitals seeking to add CT in their ED evaluate system reliability. “For us, the most important factor is reliability with little unplanned downtime followed by a strong industrial partner that can provide excellent technical and applications support.” He notes that using CT in the ED has increased exponentially in large institutions over the last decades, and new capabilities such as Iterative Reconstruction techniques will become even more important to future CT purchasing plans. “Even with the increase in scan volumes and use of CT in the ED, we can offer patients low dose with the Discovery CT750 HD.” And that, he says, is most impressive. At both St. Vincent Hospital and the University Hospital of LMU, CT is a crucial diagnostic tool for trauma and stroke patients. Speed, image quality, and applications such as GSI, perfusion, and volume rendering are impacting patient care. n Michael S. Skulski, MD, is the Department Chair of Radiology at St. Vincent Hospital & Health Services at the 86th Street campus. He graduated from University of Cincinnati College of Medicine and completed a residency in Diagnostic Radiology at Mayo Clinic in Rochester, Minnesota, where he was Chief Resident. In addition, he completed a fellowship in cross-sectional imaging at the Mayo Clinic. Dr. Skulski’s special interests include body imaging, body intervention and non-invasive vascular imaging. He is also a member of the musculoskeletal team with a special interest in foot and ankle imaging. Nicole Duckworth Nikki D. Duckworth, MBA, RT, is the Manager of Medical Imaging Services at St. Vincent Hospital (Indianapolis) at the 86th Street campus. She graduated from: American Intercontinental University with an MBA in Operations Management; Indiana Wesleyan University with a BS in Business Management; and Indiana University with an AS in Radiologic Science. She is currently studying to become a Fellow of the ACHE (American College of Healthcare Executives). Before working in management, Nikki worked as a MRI, CT, X-ray, and Nuclear Medicine Technologist. Corey W. Graff, RT(R)(CT), is a CT technologist at St. Vincent Hospital & Health Service (Indianapolis) at the 86th Street campus. He graduated from radiology school at Hancock Memorial Hospital (Greenfield, IN). As a member of Ascension Health, St. Vincent Health is a part of the largest Catholic, mission-driven, not-for-profit health care system in the United States. St. Vincent Indianapolis Hospital recently earned the Distinguished Hospital for Clinical Excellence™ recognition by HealthGrades, the leading independent healthcare ratings organization. Corey Graff Hospital for Clinical Excellence is a trademark of HealthGrades. Professor Ulrich Linsenmaier, MD, PhD, is Associate Chair, Associate Professor of Radiology, and Managing Attending Radiologist in the Department of Clinical Radiology at Ludwig-Maximilians-University (Munich). He is the 2011-2013 President of the European Society of Emergency Radiology (ESER). Areas of professional interest include: emergency radiology; interventional radiology (IR); body imaging (MSCT, MRI); and neuroradiology (NR). Professor Linsenmaier has presented more than 200 scientific talks, received three scientific awards, and authored more than 70 original articles and five books. He is a reviewer for The Lancet, European Radiology, Investigative Radiology, European Journal of Radiology, RöFo, Der Radiologe, Der Unfallchirurg. Munich University Hospital is comprised of two facilities: the nearly 973-bed University Hospital of the Ludwig-Maximilians University (LMU) and 1,349-bed Grosshadern campus. Approximately 500,000 patients receive medical care from the 45 departments and institutes at both campuses. Recognized as one of the major university hospitals in Europe, Munich University Hospital conducts 50,000 surgical interventions each year and is known for its pioneering work in cardiosurgery and outstanding transplantation expertise. 38 A GE Healthcare CT publication • www.ctclarity.com l o w - d o s e p e d i at r i c i m a g i n g clinical value Pediatric Hospitals Bring Low-dose CT to the Middle East For years, radiologists have been cognizant of the importance of limiting pediatric patients’ exposure to radiation dose. Building on the ALARA principle, the Image Gently Campaign specifically targets awareness of radiation dose levels to children and young adults. This is the case in the Kingdom of Saudi Arabia. There, two leading hospitals are using ASiR to enable a reduction in the radiation dose delivered to pediatric patients while maintaining image clarity to provide effective patient treatment.** However, reducing radiation dose based on a reduction in kV sometimes results in noisy images that can negatively impact the radiologist’s diagnostic capabilities. For acutely sick children, such as those afflicted with heart ailments (anomalies) or pediatric cancers, treatment planning often requires high-quality CT images. Yet, radiologists may, in some instances, be hesitant to order additional CT exams out of concern that the pediatric patient is being repeatedly exposed to medical imaging radiation. The beat goes on At King Abdulaziz Cardiac Centre, Dr. Fahad Al-Habshan, a consultant in pediatric cardiology and cardiac imaging, uses CT to image children prior to open heart surgery. “We tried to use a lower radiation dose in our CT imaging, but the images were noisy and hazy,” Dr. Al-Habshan says. “It is always a balance between the radiation dose and the clarity of the image, particularly when it comes to small children where we are “With ASiR, we obtain the same quality images at a much lower dose—it reduces the noise and produces crisp images.” Dr. Fahad Al-Habshan **In clinical practice, the use of ASiR may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. www.gehealthcare.com/ct • November 2011 39 c l i n i ca l v a l u e l o w - d o s e p e d i at r i c i m ag i n g A B Figure 1. Detecting aortic arch obstruction and coronary compression in a 13-month-old girl using gated CT angiography with ASiR (0.8mSv). (A) Sagittal view reveals the aortic arch and an area of coarctation. (B) 3D reconstructions of the heart demonstrating the aortic anastomosis and the Right Ventricle—Pulmonary Artery conduit. Calculated radiation dose: 20.57 X 2.16 X 0.018 = 0.8 mSv (obtained by 2007 ICRP recommendations using chest factor of 0.018 *DLP for children one to five years). looking at small vessels and structures. We need to be very accurate and precise in our diagnosis of pediatric cardiac patients, and that has complicated our efforts to reduce dose.” Specifically, the pediatric cardiology surgeons require high quality images for surgical planning. “Everything in the operating room is carefully planned; surprises add precious time that can increase the complications for very young patients,” he adds. Good images help the surgeon conduct the procedure in the shortest time possible to minimize risk to the patient’s safety. “Children are more sensitive to radiation,” says Dr. Al-Habshan. However, when the hospital’s LightSpeed* VCT received an ASiR upgrade in September 2009, low-dose CT imaging became a reality. “With ASiR, we obtain the same quality images at a much lower dose—it reduces the noise and produces crisp images,” explains Dr. Al-Habshan. The difference is significant. “Today with ASiR, almost all our children are imaged with less than 1 mSv radiation dose,” he adds. “GE is focused on developing hardware and software that enhance image quality and lower radiation dose,” says Dr. Al-Habshan, “and I think that offers more benefit to the patient than the number of detectors.” 40 A GE Healthcare CT publication • www.ctclarity.com Figure 2. Confirming a vascular ring with mirror-image branching using CT Angiography with ASiR (0.66 mSv). 3D reconstruction of the heart shows the complete vascular ring, formed by the right aortic arch and the left-sided ductus arteriosus, around the trachea and esophagus. Also seen are the airway and the nasogastric tube in the esophagus. Notice the mirror image branching of the aortic arch, which is very unusual with this type of vascular ring. Calculated radiation dose: 11.77 X 2.16 X 0.026 = 0.66 mSv (obtained by 2007 ICRP recommendations using chest factor of 0.026 * DLP for children under one year). l o w - d o s e p e d i at r i c i m a g i n g A ray of hope As the first children’s cancer center in the Middle East, King Fahad National Centre for Children’s Cancer and Research is widely recognized as a leading institution that provides comprehensive oncology care for pediatric cancer patients throughout the region. The hospital aims to provide the best level of care in medical imaging through the acquisition of state-of-the-art equipment and techniques. A C clinical value “We are very concerned about the possibility of our patients being over-exposed to radiation dose in CT scanning,” says Lefian Al Otaibi, MD, Acting Chairman of Radiology and Head Section, Pediatric Radiology. The center treats patients ranging in age from three months to 14 years. Dr. Otaibi’s concern regarding dose began to diminish when he learned more about ASiR during the installation of the BrightSpeed Elite CT scanner. “We implemented it immediately to see the difference in image quality and dose using ASiR, and it was clearly noticed.” B Figure 3. Chest abdomen pelvis exam of 13-month-old pediatric patient; (A) volume rendered (VR) bone, liver, and kidney; (B) portal vein VR on coronal view; (C) VR with portal. Total acquisition time of 5 sec for 300 mm coverage using ASiR 50% for a DLP=59.04 mGy.cm (Equivalent dose = 0.8 mSv). DLP was 59.04 mGy.cm for an effective dose of 0.8 mSv (obtained by EUR-16262 EN, using a Chest pediatric factor of 0.013*DLP and an Abdomen Pelvis pediatric factor of 0.015*DLP). www.gehealthcare.com/ct • November 2011 41 c l i n i ca l v a l u e l o w - d o s e p e d i at r i c i m ag i n g A C In fact, the reaction from radiologists was so positive that the facility launched a new initiative to reduce unnecessary dose to patients. The initiative includes two principles of radiation protection: appropriate justification for ordering the procedure and careful optimization of the radiation dosage used during the procedure according to age and weight. “ASiR has allowed us to lower the radiation dose delivered to our patients compared to our previous scanner,” adds Dr. Otaibi. “This is a department goal for all routine studies and with all radiologists.” 42 A GE Healthcare CT publication • www.ctclarity.com B Figure 4. Chest abdomen pelvis exam of 13-month-old pediatric patient; (A) Aorta plus Aorta VR; (B) MIP Liver and CAP Vessels; (C) Minip Lungs & Bronchus; Total acquisition time of 5 sec for 300 mm coverage using ASiR 50% for a DLP=59.04 mGy.cm (Equivalent dose = 0.8 mSv). DLP was 59.04 mGy.cm for an effective dose of 0.8 mSv (obtained by EUR-16262 EN, using a Chest pediatric factor of 0.013*DLP and an Abdomen Pelvis pediatric factor of 0.015*DLP). The value of ASiR is most important in follow-up, or repeat exams, particularly for oncology patients who must often receive annual or bi-annual exams to detect any relapse. According to Dr. Otaibi, ASiR offers the radiologists the ability to conduct needed follow-up exams with decreased concerns of additional radiation dose. “Without ASiR, there are some follow-up exams we probably would not do,” he says. In addition to potentially minimizing dose with ASiR, the facility also utilizes the high pitch on the BrightSpeed Elite to decrease scan time, says Abdulaziz Bawazeer, Radiology Supervisor. l o w - d o s e p e d i at r i c i m a g i n g clinical value “ASiR has allowed us to lower the radiation dose delivered to our patients compared to our previous scanner. This is a department goal for all routine studies and with all radiologists.” Dr. Lefian Al Otaibi “When scanning children, we want them to spend less time within the gantry,” he explains. “That will further help lower radiation dose and reduce motion, which helps with image quality. We also provide artwork on the walls of the room and television screens to help keep the children more comfortable and relaxed.” With most patient cases being CAP or HN, both Dr. Otaibi and Mr. Bawazeer believe it is imperative to reduce dose in all procedures. Their results with ASiR are impressive; the studies maintain image quality and provide good visualization of contrast enhancement at lower dose and noise levels. “We are confident our patients are receiving optimized dose without affecting the diagnostic quality of the exam,” notes Mr. Bawazeer. “And that provides the potential for outstanding clinical outcomes.” At King Abdulaziz Cardiac Centre and King Fahad National Centre for Children’s Cancer and Research, ASiR enables clinicians to provide the highest level of diagnostic care at the lowest possible dose. n » www.gehealthcare.com/LowerDoseByDesign Lefian Al Otaibi, MD, is a Consultant Radiologist at King Fahad National Centre for Children’s Cancer and Research and King Faisal Specialist Hospital and Research Center. Abdulaziz Bawazeer is the Radiology Supervisor at King Fahad National Centre for Children’s Cancer and Research. The King Fahad National Centre for Children’s Cancer and Research opened in 1997. Located north of Riyadh on a two-acre site, it is an integral part of the King Faisal Specialist Hospital and Research Centre and provides both inpatient and outpatient services to Pediatric Hematology/Oncology patients. Seventy to 80 pediatric stem cell transplants are performed per year. The hospital is locally known as the Children’s Cancer Centre or CCC. Abdulaziz Bawazeer The King Faisal Specialist Hospital and Research Center (KFSH&RC) is a modern state-of-the-art hospital with 894 beds. Located in Riyadh, KFSH&RC is the national referral center for oncology, organ transplantation, cardiovascular diseases, neurosciences and genetic diseases. A full range of primary, secondary, and tertiary health care services is provided. Fahad Al-Habshan, MD, is a consultant in pediatric cardiology and cardiac imaging at King Abdulaziz Cardiac Centre, National Guards Health Affairs. King Abdulaziz Cardiac Centre is a tertiary care cardiac center in Riyadh, Saudi Arabia, that conducts approximately 400 open heart procedures on children every year. It is affiliated with one of the largest medical institutions in Riyadh, and provides both adult and pediatric care. The center receives pediatric referrals from all over the country. www.gehealthcare.com/ct • November 2011 43 ca s e s t u d y L o w - D o s e C a r d i ac I m ag i n g Low-dose CTA With ASiR Acquisition Protocol Scanner: Optima CT660 with ASiR Scan type/slice thickness: Snapshot Pulse / 0.625 mm Coverage: 40 mm Rotation time: 0.35 sec Total elapsed time: 5.1 sec Total x-ray exposure time: 1.76 sec mAs: 106.75 kV: 120 Recon kernel: Detail SFOV: Cardiac large DFOV: 25 cm Heart rate: 47 BPM BMI: 30 ASiR: 40% By Roberto Cury, MD, cardiologist, IDS (Instituro de Diagnóstico de Sorocaba) and Melissa Megumi S. Kuriki, Advanced Application Specialist, GE Healthcare Latin America When performing stent evaluation by CT, it is preferred to implement low radiation dose particularly due to the patient’s previous exposure to radiation during the stent placement procedure in the cath lab. The Optima CT660 may achieve low dose coronary CTA with ASiR and provide high-quality images for visualizing the lumen and calcified plaque.** A B Contrast Protocol Brand/type of contrast: Ioversol Figure 1. 3D images of the heart showing stents in DCA, Mg, and RCA. Contrast injection rate: 5 cc/sec A Total contrast amount: 80 cc Saline injection rate: 5 cc/sec Total saline amount: 40 cc B Figure 2. Transparent 3D images showing calcification plaque inside of the stents. **In clinical practice, the use of Veo may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. 44 A GE Healthcare CT publication • www.ctclarity.com Low-Dose Cardiac Imaging A case study B Patient history The patient is a 51-year-old male with a BMI of 30 and family history of coronary disease. Patient had atypical chest pain at the time and was indicated for CT to evaluate three stents, LDA, OM, and RCA, implanted eight months earlier to rule out in-stent restenosis. Patient findings C D Patient showed no sign of in-stent restenosis; there was presence of discrete luminal narrowing in the distal left main of the coronary artery and the right coronary artery. Discussion Figure 3. Oblique images of coronary artery showing stents and calcified plaque with high image quality without beam hardening. The Optima CT660 with ASiR provides an opportunity to conduct a low-dose CT study. Using ASiR, patient dose was reduced with high image clarity in the cardiac study. In our region, the Optima CT660 is the first CT scanner with low-dose technology, and it helps demonstrate to patients our concern regarding patient dose and the environment. In particular with the cardiac exam, we have better visualization of the coronary artery, stents, and calcified plaque. We believe this system is making a difference in our clinical diagnosis. n Figure 4. CT coronary study with 2.57 mSv acquired in 5.1 sec with prospective gated acquisition. (DLP 183.77 mGy cm with a conversion factor of ICRP 0.014*DLP) Roberto Cury, MD, PhD, FSCCT, is the Chief Executive Officer of Virtual Heart, the first cardiac imaging teleradiology group in Brazil. He is also a cardiologist and Director of Cardiac CT and MRI at Samaritano Hospital (Sao Paulo, Brazil). Dr. Cury received his doctorate degree from Santa Casa School of Medical Sciences in Brazil and finished his clinical fellowship in Cardiac CT and MRI at InCor, Heart Institute of Sao Paulo. Dr. Cury was a pioneer in Brazil in the field of Stress Myocardial Perfusion Cardiac CT and concluded his PhD at InCor, Heart Institute of Sao Paulo. He has contributed to the field of cardiovascular imaging with published papers, book chapters, case reports, and invited presentations. Dr. Cury is currently the Director of the SCCT Brazilian International Regional Committee. Instituto de Diagnósticos Sorocaba (IDS) was founded in 1996 by radiologists who embraced a mission to provide differential and compassionate medical service. Today, IDS provides high-quality diagnostic care to approximately 500 patients each day, offering complete diagnostic services for various laboratory testing and diagnostic imaging, the latter including the latest advanced equipment such as the Optima CT660. The organization’s management team guides and monitors all activities to ensure fulfillment of the company mission and philosophy and, as a result, IDS has won the confidence and loyalty of physicians and the local population. www.gehealthcare.com/ct • November 2011 45 ca s e s t u d y l o w - d o s e p e d i at r i c cta Confirming a Diagnosis of Double Aortic Arch in a Newborn Acquisition Protocol Scanner: LightSpeed VCT Scan type/slice thickness: Non-gated/ 0.625 mm Scan range: 95 mm, aortic arch to diaphragm mAs: 120 mA kV: 80 kV Gantry rotation: 0.4 sec Radiation time: 0.9 sec Reconstruction: ASiR at 30% DLP: 9.36 Calculated radiation dose: 9.36 X 2.16 X 0.026 = 0.5 mSv (using ICRP 2007 conversion factor of 2.16) By Fahad Al Habshan, MD, Consultant, Pediatric Cardiology and Cardiac Imaging and Program Director, Pediatric Cardiology Fellowship, King Abdulaziz Cardiac Center, National Guards Health Affairs Managing children with congenital heart disease (CHD) requires accurate diagnosis prior to intervention—a task most often accomplished with echocardiography as the primary diagnostic tool. However, it is not always successful, given the ultrasound’s inherent limitations in the presence of air, bone, scar, or obesity. In addition, this modality does not always demonstrate in sufficient detail the complex extra-cardiac vascular structures, and airway and lung pathologies associated with CHD. When echocardiography is unable to render a definitive diagnosis, alternative tools must be applied—tools such as CT angiography (CTA). It has been proven an excellent alternative, generating detailed images of structures throughout the thorax. However, the trade off is radiation exposure, which is of special importance for small children and infants. With GE Healthcare’s Adaptive Statistical Iterative Reconstruction (ASiR), it is now possible to capture high-quality CTA studies of small children and infants at very low radiation dose levels.** Patient history A newborn was diagnosed antenatally with a double aortic arch. A non-gated, low-dose CTA exam was ordered to help confirm the diagnosis and assess the airway. A B Figure 1. (A) Axial MIP reconstruction at the level of the two aortic arches. RAA: right aortic arch, LAA: left aortic arch. (B) Dose report showing the very low dose with DLP of 9.36. **In clinical practice, the use of ASiR may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. 46 A GE Healthcare CT publication • www.ctclarity.com l o w - d o s e p e d i at r i c c ta Results and findings case study A A double aortic arch with a complete vascular ring around the trachea and esophagus is clearly visible in an axial view (Figure 1A). The radiation dose report (Figure 1B) highlights the low dose used in this study. The 3D reconstructions include a posterior view (Figure 2A), demonstrating the double aortic arch with a complete vascular ring around the trachea and esophagus. Another view (Figure 2B) shows the airway and nasogastric tube in the esophagus. The infant underwent surgery to divide the smaller left aortic arch and the ligamentum arteriosum that is located on the left side. The CTA images served as the surgeon’s primary roadmap for planning this repair; they gave him a very clear image in his mind and on the operating-room screen, improving the quality of care delivered to this patient. B Discussion Recent advances in CTA have made it an even more useful diagnostic tool. For example, state-of-the-art multi-detector CT scanners have reduced scan times to just a few seconds. In children in particular, multi-detector CTA’s speed may allow the physician to minimize or eliminate the need for general anesthesia or deep sedation, which is a tremendous advantage in this population. Furthermore, its spatial resolution promotes accurate diagnosis of anomalies involving the systemic and pulmonary veins and arteries, as well as the coronary vessels. Fortunately, the issue of radiation exposure is now being addressed with today’s most advanced CT scanners, thanks to new scanning protocols and software. ASiR has demonstrated its ability to produce images of exceptional clarity and signal-to-noise at lower radiation doses. The result is we can scan many of our young patients, including infants and small children, at doses of less than 1 mSv with consistently excellent image clarity. n Figure 2. (A) 3D reconstruction with a posterior view showing both aortic arches. RAA: right aortic arch, LAA: left aortic arch. (B) 3D reconstruction with a posterior view showing both aortic arches, the airway (blue), and a nasogastric tube in the esophagus (green). RAA: right aortic arch; LAA: left aortic arch Fahad Al Habshan, MD, is Program Director, Pediatric Cardiology Fellowship, at King Abdulaziz Cardiac Center, National Guard Health Affairs (Riyadh, Saudi Arabia). Dr. Habshan is also Assistant Professor, Cardiac Sciences at King Saud Bin Abdulaziz University for Health Sciences (Riyadh). He specializes in pediatric cardiology and cardiac imaging. As the largest and most advanced medical complex in the Kingdom of Saudi Arabia, National Guard Health Affairs (NGHA) includes medical “cities”strategically located across the land. Perhaps the most impressive of them all is King Abdulaziz Medical City in the capital of Riyadh. This stateof-the-art center is equipped with nearly 1000 beds for conventional, surgical and emergency admissions, and offers nearly all medical specialities—from Pediatric Cardiology and Emergency care that are second to none, to the full range of leading-edge Ambulatory, Primary, Preventive, Surgical and Critical Care services. It boasts the lowest mortality and morbidity rates in the nation. Educating the healthcare providers of tomorrow is also high on the list of the NGHA’s objectives—an objective that is being addressed via the pioneering King Saud Bin Abdulaziz University for Health Sciences, where our author serves as an assistant professor of Cardiac Sciences. www.gehealthcare.com/ct • November 2011 47 ca s e s t u d y L O W - D O S E N E U R O W I T H A Si R Critical Low-dose Neuro Imaging with ASiR Detection of cerebral Arterio-Venous Malformation (AVM) using VHS on Lightspeed VCT Acquisition Protocol Scanner: Lightspeed VCT with ASiR Scan type/slice thickness: Volume Helical Shuttle/5 mm Coverage: 160 mm Rotation time: 0.4 sec Total elapsed time: 31.16 sec Total x-ray exposure time: 17.16 sec mAs: 150 mA kV: 100 Need parameter 10 passes Recon kernel: Soft SFOV: 32.0 cm DFOV: 22.1 cm Effective dose (1207.30 [Total DLP] x 0.0023 [Tissue Factor] for head with phantom 16 cm = 2.77 mSv. (As per ICRP-60 tissue weighting factor.) Contrast Protocol Brand/type of contrast: Iopamidol Contrast injection rate: 4 ml/sec Total contrast amount: 60 ml Saline injection rate: 2 ml/sec Total saline amount: 30 ml By Zakir Hussain, MBBS, MD, PhD, Fellow-AIE-Japan, Consultant Radiologist, Square Hospitals Ltd, Dhaka, Bangladesh; and Karthik Anantharaman, MD, Marketing Manager–CT (South Asia), Muhammad Sadiqur Rahman, Product Specialist–CT (Bangladesh), and Nitin Bhardwaj, Clinical Application Specialist–CT (East Zone–India) from GE Healthcare Beginning with the first CT scanner, CT radiation dose has been a concern in medical imaging. Even before the advent of multi-detector CT (MDCT), there have been innovations aimed at developing different techniques to reduce radiation dose and improve image quality. Dose reduction techniques such as Automated Exposure Control and BMI-based protocols for cardiac scanning and application of different image space filters have been successful in helping us limit radiation exposure to patients undergoing CT scans. All of these techniques provide the desired level of optimized dose management. Filtered Back Projection (FBP), the conventional technique in use for almost three decades to reconstruct the images from raw data, still falls short of expectations when it comes to obtaining the full potential of reducing radiation dose. A recent alternative technique is the use of Iterative Reconstruction (IR) to overcome the limitations of FBP. Adaptive Statistical Iterative Reconstruction (ASiR) is an IR technology that may help clinicians achieve a confident diagnosis with lower dose.** ASiR may also enable improvement in low contrast detectability. In routine imaging at Square Hospitals Ltd, Dhaka, we normally use 40% to 50% ASiR consistently for all studies. The following is a case that demonstrates the benefit of ASiR for us in low-dose, critical, neuro-imaging applications. Patient history A 45-year-old male with known right fronto-parietal AVM presented to the radiology department. Previous history revealed that a CT-guided stereotactic radiosurgery was performed in November, 2000. The Volume Helical Shuttle (VHS) scan technique was used to achieve the low-dose, multi-phasic imaging of the brain vasculature. **In clinical practice, the use of ASiR may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. 48 A GE Healthcare CT publication • www.ctclarity.com L O W - D O SE N EU R O W I T H ASi R A B C D E F case study Figure 1. VHS Study demonstrating AVM in the right frontal and parietal lobes where the feeder vessel is coming from the right MCA and the right ACA. Results Right-side frontal and parietal AVM was noted with right middle cerebral artery (MCA) and right anterior cerebral artery (ACA) as feeder vessels and superior sagittal sinus and branch of right transverse sinus being the draining veins. Volume Helical Shuttle (VHS) was a very useful technique to help us detect feeder and draining vessels of an AVM. Discussion At Square Hospitals Dhaka, we recently upgraded our LightSpeed VCT system to include ASiR. Until the upgrade, physicians referring their patients for CT scans to our department were concerned with the additional radiation exposure in follow-up scans. This fear has now been addressed with the introduction of ASiR on the upgraded LightSpeed VCT system. We can now demonstrate to our referring physicians the capability to deliver lower radiation dose with ASiR on our CT scanner and, hence, build confidence among them to refer patients for follow-up studies. In our experience, ASiR is a significant advancement in CT dose optimization technology that balances image quality, noise, and dose. ASiR has made low-dose imaging across body regions a reality in our facility. In addition, VHS aids our clinical diagnosis significantly through extended coverage with multi-phasic information. It also helps achieve different phases of contrast for the desired anatomy with a fixed amount of contrast. n Mohammad Zakir Hussain, MBBS, MD, PhD, is a Consultant Radiologist and Head of the Department of Radiology and Imaging at Square Hospitals Ltd. (West Panthapath, Dhaka, Bangladesh). Dr. Hussain received his Doctor of Philosophy in Medical Science (Clinical Subject: Radiology) from the Yamanashi Medical University and his Bachelor of Medicine & Surgery (MBBS) Examination from the institute of Post Graduate Medicine & Research (IPGMR) under the University of Dhaka, Bangladesh. He also completed a post-doctoral fellowship at Yamanashi Medic al University (Japan). Dr. Hussain’s clinical interests are in MRI, CT, and MRS, with special emphasis on coronary CT angiogram and other CT and MR angiogram studies. He helped establish the Interventional Radiological Center of Square Hospital Ltd. Square Hospitals Limited is a 320-bed, tertiary care hospital. The hospital is an affiliate partner of Methodist Healthcare (Memphis, TN USA), SingHealth (Singapore), Bangkok Hospital Medical Centre, (Thailand), and Christian Medical College (Vellore, India). Square Hospital is located in the heart of Dhaka and aims to serve a greater portion of the capital city. At present it is comprised of: The main hospital building is 18 stories and approximately 450,000 sq. ft.; the second building (ASTRAS) is located across the street and is 16 stories with 136,000 sq. ft. www.gehealthcare.com/ct • November 2011 49 ca s e s t u d y ONCOLOGY WORKFLOW Multi-modality Oncology Workflow for Comprehensive Follow-up and Treatment Acquisition Protocol By Valerie Laurent, MD, PhD, radiologist, Central University Hospital, Nancy Scanner: LightSpeed VCT Scan type/slice thickness: Helical 1.25 mm Abstract Pitch: 1.375 Rotation time: 0.6 mAs: 338 OncoQuant has proved to be an invaluable tool for tracking of oncology studies in our facility. We can compare a seemingly limitless number of CT, MR, and PET exams. Moreover, OncoQuant provides a structured workflow for using base lining and NADIR to determine patient response to treatment according to RECIST guidelines. kV: 120 Patient history The patient is a 47-year-old male with liver metastases of an endocrine tumor in the pancreas. Palliative treatment: first line chemotherapy in December, 2006. Software • Dexus workflow software(s) used: OncoQuant • Length of time used at site: 1 year, used routinely (daily) • Platform used (Wkst/Server): AW workstation Patient findings The patient returned for evaluation in December, 2010. There was a partial response to treatment followed by progression, and the NADIR was set to the date with the best response to treatment as per RECIST guidelines. The summary table was used to assess the percentage of disease progression from NADIR (Figure 1). If the calculation is made from the original baseline, the tumor growth since December, 2006 is 11% (Figure 2). But it is important to consider that the gold standard is NADIR according to RECIST guidelines. Using the RECIST methodology, the October, 2009 review becomes the new reference (NADIR) from which the progression of the disease should be evaluated. Using the summary table in Figure 1, we can clearly see that there is an evolution of 73% of the lesions based upon the RECIST 1.1 criteria (total of Dmax of the initially identified target lesions). This indicates there is a progression of the tumor, and, therefore, a need to change patient treatment. 50 A GE Healthcare CT publication • www.ctclarity.com ONCOLOGY WORKFLOW case study Figure 1. Summary Table Discussion There are relative inconsistencies with the planning of treatment and follow-up of oncology cases between different sites and even between oncologists at the same hospital. Although the results are directionally correct, repeatability and reproducibility are often challenges when it comes to comparative results. With OncoQuant, we were able to establish a consistent, repeatable, and rapid diagnostic workflow across different cases and physicians, even utilizing exams from several years prior as a baseline. We came to find that through this workflow, we were able to achieve: • Quick comparison of follow-up exams from the baseline exam; • Comparison of several exams without virtually any apparent limit; • Cross registration of chosen target lesions from lesions in the initial exam; • Comparison of measurements obtained with an automatic registration between the initial exam and follow-up exam; Figure 2. Reference of current to the baseline. www.gehealthcare.com/ct • November 2011 51 ca s e s t u d y ONCOLOGY WORKFLOW A B Figure 3. Tracking one of the targets on the three first exams. C • Consistent results that are table and operator independent; • Clinical answers that are less tedious to perform and more objective and independent of the modality, acquisition technique, and clinician; • Automatic registration of either two or three different modalities; • Comparison of parametric data, diffusion, perfusion curves, and SUV integration of different morphological criteria: RECIST 1.1 (standard), RECIST 1.0, WHO, and any other configured/ user defined criteria; and • Monitoring of volume evolution even if not stated in the RECIST guidelines. Overall, OncoQuant provides a structured and repeatable workflow that improves the speed and efficiency of follow-up reviews and creates a method to initiate a standardized dialogue between several physicians in our network. n Valérie Laurent, MD, PhD, is a radiologist at the Central University Hospital, Nancy (Nancy-Brabois, France). Dr. Laurent has spent over 12 years focusing on abdominal imaging in oncology and during that time has used MRI and CT extensively. She recently received her doctorate degree in 2010. The Central University Hospital of Nancy comprises a hospital network of over 1,600 beds serving over 600,000 patients with 30,000 emergency entries a year. There are two main locations: one in the center of Nancy and the other in the suburbs of Brabois. Inaugurated in 1973, the Hospital Brabois for Adult Studies is the cornerstone of the Brabois hospital network serving first as a university hospital within close proximity to the Faculty of Medicine and secondly as the premier regional center for combating cancer with over 945 beds. 52 A GE Healthcare CT publication • www.ctclarity.com GE Healthcare The rules of CT imaging have changed. Introducing Veo,™ the world’s newest low dose technology from GE Healthcare. See the Veo Case Study highlighting 0.07 mSv Chest CT exam with Discovery CT750 HD with amazing image clarity. Innovation is our passion, that’s great care by design. Available on Discovery CT750 HD SEE MORE... Visit us! gehealthcare.com/LowerDoseByDesign & at RSNA: South Building, Booth #3335 Patient Care Image Quality Lower Dose © 2011 General Electric Company DOC 1041480 tech n i ca l i n n o v at i o n veo Understanding the Impact of Iterative Reconstruction A new paradigm in the assessment of radiation dose and image clarity GE Healthcare CT is undergoing a multi-year commitment to investigate a multi-center study to further demonstrate the clinical translation of Veo, which is a full model-based iterative reconstruction (MBIR) capability. The technical innovation and design of this technique demonstrate the potential for radiation dose reduction and improvements in image clarity. CT Clarity recently spoke with two experts leading the efforts to quantify the impact on diagnostic value: Ehsan Samei, PhD, Professor of Radiology and Medical Physicist at Duke University, and Rendon Nelson, MD, Reed and Martha Rice Professor of Radiology at Duke University. Dr Samei and Dr. Nelson share, in their words, what they have learned from the phantom and clinical work to date. Q: Why, in your opinion, are these studies important to undertake? Dr. Samei: I believe that radiology is a science. As scientists we make predictions, have expectations, and conduct studies. Yet, ultimately, whatever we predict and expect to see must be confirmed. We often find, from a theoretical or scientific standpoint, that one solution could have certain advantages, but when we conduct the clinical trial we realize that certain nuances in that prediction may have been overlooked. Based on this belief, while there is strong scientific evidence that the new iterative reconstructions (IR) are advantageous, we want to further investigate the potential of MBIR through a clinical trial. In the spirit of scientific work, we need continued information for ourselves and for our community—that what we predict and claim is more broadly proven out. Dr. Nelson: I agree with Ehsan that it’s important to validate the results from the phantom trial that we conducted. In actuality, what we originally projected to achieve in dose reductions (in the patient trial) is likely more aggressive than what we found was possible based upon the phantom data. Certain numbers, such 54 A GE Healthcare CT publication • www.ctclarity.com Ehsan Samei, PhD as contrast-to-noise-ratios (CNR), don’t tell the whole story. There are other parameters indicating that while CNR is higher, the noise is above and beyond a certain threshold where we are comfortable diagnosing from those images. So now, we also have to investigate if our predicted level of dose reduction is adequate from a diagnostic standpoint. More importantly, from my standpoint, this is an opportunity to do something truly unique. The CT manufacturers are all talking about dramatic dose reductions using IR, but the only way that we can comprehensively demonstrate what a particular technique can do in the varied and changing clinical setting is through a comprehensive clinical trial that extends globally across different practice settings. veo t e c h n i c a l i nn o v a t i o n extremely important that we do not compromise diagnostic image quality in the process of acquiring patient images. IR, and MBIR in particular, may help achieve a confident diagnosis with lower dose.** That is the most exciting part here—finding a better balance between image quality and radiation dose. Q: Considering the various clinical tasks of high and low contrast and resolution, what has surprised you the most in your findings with MBIR? Dr. Samei: CNR has been the basis of image quality quantification for decades, starting with a 1948 landmark publication. An underlying assumption is that the resolution of an imaging system does not change as a function of dose or contrast. The noise changes with lower radiation dose—the image becomes grainier—but the resolution, or the sharpness of the features, does not change. Rendon Nelson, MD Q: What interested you most in agreeing to participate in this clinical research? Dr. Nelson: I’ve been reading CT scans for 25 years. We were very excited when the first multi-slice scanners were introduced. We had the opportunity to do fast imaging, thin slices, and multi-planar reconstructions (MPRs) routinely. But then we realized higher radiation doses were in some cases the price we paid for these additional capabilities. Higher radiation dose has become a public issue and I’m very interested in the impact of it. It seems that while some headway has been made by the manufacturers, the burden to reduce radiation dose remains squarely on the shoulders of the radiologists. While we, as radiologists, are getting better at interpreting higher noise and lower quality datasets for diagnostic purposes, at times we find ourselves on the edge of image quality. This study represents an opportunity to address this challenge in a way that doesn’t firmly rest on the radiologists’ ability to read images with high noise. Dr. Samei: What excites me about IR is that it highlights the need for a better appreciation and quantification of image quality in CT imaging. We have been very concerned about radiation dose and there is a great deal of responsibility to reduce radiation dose. But, while trying to reduce patient dose, we need to realize that patients do not come to a medical center to get dosed; rather they come to get imaged. So therefore, it is What surprised me the most looking at MBIR is that resolution does change as a function of contrast and dose. So, with MBIR it was not what a CT medical physicist would naturally expect. As a result, resolution can be potentially higher but on the flip side, the methodology that we have relied upon these last 50 years goes out the window. If the goal of optimizing imaging is to come up with a balance between image quality and radiation dose, then we don’t have an ideal metric to measure image quality and achieve that balance. We cannot optimize something that we cannot ideally measure. This “discovery” has initiated a new line of research in imaging physics, namely to develop better metrics of measuring image quality that can replace CNR. Dr. Nelson: As Ehsan has alluded, the phantom study uncovered higher CNR with the MBIR technique using up to 90% less dose. Yet, when we looked comprehensively at the images, the noise level at 90% less dose was not well received by the radiologists who qualitatively examine the images. So, CNR is not the whole picture. Based on the phantom data, which we know does not always directly translate to clinical acceptance, we can predict to achieve a 70% dose reduction—and that is not from FBP but rather from the ASiR technique. At our institution, ASiR protocols reflect dose that is approximately 40% to 50%** of our current standard of care FBP protocols, and MBIR will be investigated at 70% lower than that. This is a very aggressive approach, considering that in the abdomen and pelvis our ASiR dose is typically 3 to 7 mSv. This very low dose provides interesting ramifications from a clinical standpoint. **In clinical practice, the use of MBIR and ASiR may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. www.gehealthcare.com/ct • November 2011 55 tech n i ca l i n n o v at i o n veo I would also add that clinically these images look different, although they have very good spatial resolution and low contrast detectability even at low doses. Different doesn’t mean bad; it just means different and is something that imagers would have to get used to, particularly those that have been doing interpretations from FBP for many years. Q: What have you found to be the most important lessons in assessing image quality and clinical value in the transition from FBP to MBIR? Dr. Nelson: Through a consortium, whereby we selected a small number of opinion leaders, initially there was a lot of concern about the difference in image appearance. Not so much the difference in noise but the different look and feel that I alluded to earlier. But a very interesting thing happened. We realized, as imagers, that even though the MBIR images looked different, we weren’t missing anything and in some cases, we saw more information. In our experience, a method for helping radiologists get used to the different appearance of these images is to start out by doing a side-by-side comparison of standard-of-care dose FBP and MBIR datasets followed by a gradual diminution in dose. Using this format, we have noted a shift in the radiologist focus from concern over the different ‘look and feel’ to a discussion of ‘how low can I go’. Dr. Samei: One of the amazing skills that a radiologist has when interpreting an image is that he/she is able to distinguish between artifacts and true anatomy. They know that noise is a characteristic of acquiring images with a limited amount of dose. Provided they know that the images are noisy, they can feel confident reading through that noise. 56 A GE Healthcare CT publication • www.ctclarity.com With IR, we have changed the nature of noise. Essentially, our task is to identify what is real and what is artifact, in the broad sense of the word—something that is not reflective of patient anatomy or function. With IR, there is still noise in the images; even though the magnitude is lower, the texture of it is different. As long as the radiologist knows that texture and understands how it manifests itself, he/she will still be able to do a great job reading through the image. So there are two elements: there is a training element of understanding the noise texture, and another element is quantifying the actual limitation that the noise texture would put on the maximum amount of information that radiologists can extract from the image. Q: What can your peers expect to learn from both the phantom and the clinical study? Dr. Samei: The phantom study provides us with new tools and methods to characterize image quality for MBIR, taking into account some of the resolution and noise features of the reconstruction that I mentioned. It also provides us with a scientific basis to determine what level of dose reduction is possible with MBIR without compromising diagnostic quality. The clinical study will help to substantiate the predictions of the phantom study clinically, while at the same time providing a wealth of information to refine the image quality metrology further. Dr. Nelson: The phantom study results were used to build the multi-center trial, but from those results I hope that: a) they will first be confident that the technique settings we’ve chosen are adequate and that they can assimilate them into their own veo t e c h n i c a l i nn o v a t i o n practice; and b) that the image quality is such that they are confident they can make diagnostic reads from images at this low dose of radiation. Ultimately, our culture tends to get fired up on something based on an issue and that’s true with radiation dose. And that burden is upon us (and includes publishing the results from this multi-center clinical trial) to prove to the public that the doses used in CT imaging do not pose a medical concern to them. Q: Considering model-based iterative reconstruction, what do you see as the implications for CT imaging in clinical practice? Dr. Samei: There are two things. We have talked a great deal about reducing radiation dose, and that is a huge implication of IR clinically. But what excites me even more is that we have the opportunity to be on the cutting edge of doing more with medical imaging—extracting more meaningful information about the patient. It is possible that we might not reduce dose as dramatically, or even at all for certain applications, in order to take advantage of the additional information we get from IR. There are new applications that we may be able to explore. So we could now have a new tool in our arsenal to obtain better information from the patient that would be more clinically meaningful. Dr. Nelson: There are two challenges. First, we need to figure out what radiation dose levels and reductions are appropriate and reasonable using this technique, particularly in comparison to the competitive IR techniques on the market right now. Second, we have to become comfortable with the new look and feel of these images. But remember like PACS, in a short period of time, we will have a new group of radiologists coming through the training programs who may never see an image from FBP. Just like with all our 48 residents, they have never read plain film, they are all trained using PACS. So it’s just a matter of time to make that cultural change, but it will be a new experience at the onset for those who have been reading images from FBP for many years. In terms of implications for CT imaging, I think MBIR will have a higher impact on CT imaging of the chest, abdomen, and pelvis. And, these anatomic regions are where we give the highest dose levels since we often do multiple passes following the administration of contrast material. We have no problem doing that in MR but in CT the doses accumulate. So I think we’ll see a big impact in CT body imaging. The Pilot Study of Model-based Iterative Reconstruction using 64-Slice Multidetector-Row CT Datasets Obtained from the Central Nervous System, Thorax, and Abdomen is designed to provide further evidence of the diagnostic clinical value of Veo image reconstruction. Prior phantom studies have demonstrated a significant dose reduction potential while maintaining or improving quantitative image quality metrics as matched to observer results. This study translates those details into the clinical population via acquisition of data at two different dose levels on the same study subject, then each are reconstructed utilizing three techniques, FBP, ASiR, and Veo. Image volumes from subjects scanned for pathology in the posterior fossa, lung cancer staging, focal liver lesions, or kidney stones will be reviewed by two independent readers blinded to subject, radiation dose level, and image reconstruction type. Readers rate the ability to detect and characterize pathology of interest as well as provide an overall indication of diagnostic value including artifact level and impact to recommended treatment path. Incorporation of results from these four anatomical regions at both radiation dose levels will enable evidence of clinical behavior in tissues presenting both high and low contrast and resolution challenges for broad assessment of diagnostic image clarity. Three leading academic institutions in the US are enrolling 120 subjects for this pilot study, which is underway. Pilot results will be used to fine tune future studies across the globe. www.gehealthcare.com/ct • November 2011 57 tech n i ca l i n n o v at i o n veo Dr. Nelson: We are embarking on a comprehensive evaluation of a new technique and I’m hopeful that this will set the precedence for future clinical trials that aim to provide more comprehensive investigations of new techniques. What I like about this MBIR trial is the technology is relatively new and we’ll get the results in a relatively short period of time. We’ll publish the results, hopefully in the next year, and the impact should be much higher. So it will be interesting to see what happens—it is a big commitment both financially and in terms of allocating resources. It was a significant scientific investment. We also encourage the radiology community to continue evidence-based studies across the specialty. n Q: Any additional thoughts? Dr. Samei: One of the beautiful things about CT imaging is that the field was somewhat homogeneous before IR. Moving forward, we’ll have a whole lot more heterogeneity in the CT operation clinically—not in terms of one manufacturer but across manufacturers. There is a new challenge for imagers—a call to action—for standardization. In order to confirm the claims by manufacturers, we need comparable images (from different manufacturers), so I think we need to be mindful of that as IR is rolled out. I do, however, believe this clinical trial is a great step in that direction, though limited to a single vendor trial. We should be seeking to create a framework that different sites can implement, so that we can all achieve a certain level of consistency in image quality evaluation, in how we discuss image quality improvement, and in dose reduction. » www.ctclarity.com/ctclarity/veosupplement2011#pg1 to read the full interview. Ehsan Samei, PhD, DABR, FAAPM, FSPIE is a Professor of Radiology, the Director of Carl E. Ravin Advanced Imaging Laboratories, and the Founding Director of the Clinical Imaging Physics Group at Duke University. His research interests include advanced X-ray imaging techniques, translational medical imaging, and image quality and dose metrology aimed towards optimized interpretive, quantitative, and molecular performance. He has been the recipient of 20 extramural grants and has over 500 publications, including 130 referred papers. Rendon C. Nelson, MD, FACR, FSCBT-MR, is the Reed and Martha Rice Professor of Radiology at Duke University. He is also a Fellow in the American College of Radiology and both a Fellow and Past President of the Society of Computed Body Tomography and Magnetic Resonance. He is a member of the Division of Abdominal Imaging at Duke with clinical interests in hepatobiliary and pancreatic imaging, virtual imaging, percutaneous image-guided intervention, and percutaneous thermal tumor ablation. His research interests include: (1) optimization of diagnostic imaging of the liver, specifically the detection and characterization of focal and diffuse processes by US, CT, and MRI; (2) optimization of radiation dose and image quality in multidetector CT of the body; and (3) percutaneous image-guided thermal ablation of hepatic and renal tumors. As a leading academic medical center, Duke University is uniquely positioned to transform medicine and health locally and globally through innovative scientific research, rapid translation of breakthrough discoveries and educating future clinical and scientific leaders. Duke is a strong advocate of practicing evidence-based medicine and is a leader in efforts to eliminate health inequalities. Each year, the 15,000 professionals of Duke University Health System serve patients through more than 60,000 hospital admissions and 1.8 million outpatient visits. For 21 consecutive years, Duke University Hospital has been named among the top 10 in the nation by U.S. News & World Report. 58 A GE Healthcare CT publication • www.ctclarity.com GE Healthcare Greater Clarity. At digital speed. Online. And on tap. Now you can have complete issues of GE Healthcare’s CT Clarity, the Magazine of CT, right at your fingertips when you’re on the go. The CT Clarity App links you to a vital source for the latest news about GE Healthcare CT on your iPad, iPhone, or Android tablet or phone. Download the free tablet and smartphone applications at the Apple Store (www.apple.com) or Android Market Apps (www.market.android.com). Or, simply scan the QR code below with your smartphone. Follow us on Twitter: @GEHealthcare imagination at work ctclarity.com © 2011 GE Healthcare, a division of General Electric Company. iPhone and iPad are registered trademarks of Apple, Inc. Android is a trademark of Google, Inc. Android Apple tech n i ca l i n n o v at i o n dexus Integration and Information the Cornerstone of Radiology By William P. Shuman, MD, FACR, Director of Radiology, University of Washington Medical Center Radiology embraced the digital revolution more than 20 years ago. In most hospitals today, radiologists perform their diagnoses in virtually an all-digital environment. Alternate care sites— clinics and physician offices—are quickly following in the same direction, if they are not already there. However, as imaging and information technology advanced at varying levels over the past two decades, radiology departments have become a multisystem environment. As a result, radiologists utilize an array of systems—many from different manufacturers—to read and report the patient diagnosis. These systems include, but are not limited to, PACS, RIS, HIS, Speech Recognition, and advanced image processing. As technology changes, so too does our expectation of the technology. We expect it to positively impact patient care by enabling us to see the body more clearly with advanced imaging 60 A GE Healthcare CT publication • www.ctclarity.com or post-processing techniques, and enhance our workflow for physician accuracy and efficiency (particularly important in emergency cases). Yet, this multi-system electronic environment may present a barrier to workflow and efficiency. Advanced processing workstations were historically separate workstations. Native to these systems are 3D and other advanced image post-processing software. Radiologists had to pause in their analysis, physically move to the image processing workstation, perform the image analysis, and then push the data back to the PACS. In this scenario, efficiency and seamless connectivity of patient information was lost. Recent integration of advanced processing capabilities to the PACS diminished the need to utilize a stand-alone workstation. This was often accomplished by providing dexus access to an advanced application server via the desktop. While this configuration worked, it still presented significant workflow challenges. With multiple systems already open on the workstation—HIS, RIS, PACS—the radiologist was required to navigate and locate/ manage the desktop mindshare. Perhaps more important is speed and functionality. At the University of Washington, we use most of our advanced processing capabilities (as do other sites) with CT colonography, cardiac, spectral dual energy, and vascular imaging. Having a dedicated advanced image processing workstation (i.e., AW Workstation) just 20 feet away from the PACS workstation made it tempting to go over and work on it. However, this defeated the purpose of a single desktop. As radiologists are well aware, interruptions to the diagnostic process, including moving to a dedicated processing workstation, diminish efficiency and productivity. While increases in network and processing speed helped address these issues, a fully integrated program that allowed us to seamlessly access PACS, RIS, advanced image processing, and other applications at the same time, on the same workstation, t e c h n i c a l i nn o v a t i o n was highly desired. At our facility, we recently implemented a new solution that integrates GE’s new AW Server to our RIS-driven workflow with impressive workflow efficiency results. Dexus workflow An integral part of Dexus is the AW Server integration to PACS and RIS for a single imaging workflow. It also leverages a central PACS database to enable access to a broad array of advanced 3D visualization and processing tools typically found on the AW. This environment provides a substantial improvement in the speed of image post-processing on the PACS. System usability is also enhanced due to transparent image sharing between AW and PACS. By using a thin-client architecture, AW Server enhances the value of remote access to patient information. This is especially important for our multi-site healthcare system, where we now have the ability to scan a patient at any location and provide the same level of interpretation and analysis regardless of where the radiologists are situated. www.gehealthcare.com/ct • November 2011 61 tech n i ca l i n n o v at i o n dexus “Remember, as radiologists, we are integrators of information, and the more our tools complete these tasks for us, the more efficient we can be in our diagnoses and consultations. ” Dr. William P. Shuman Speed has historically been an issue with advanced postprocessing in the PACS. It is important that speed be independent of location—it is the same whether the images are being sent from a facility in another city or state, or three doors down the hall. By addressing the speed issue, we anticipate the AW Server will further impact our ability to perform more advanced analysis from virtually any location, including at-home night reads when on-call. As radiology subspecialties continue to grow in demand, speed will become even more important in the near future. Clinical collaboration among and between specialties will also be further enhanced. Utilization of advanced applications in our diagnostic workflow will increase in our daily routine and in training residents and fellows. When access was cumbersome and required an interruption in workflow, there was a natural reluctance on the part of the radiologist to use 3D image analysis. Frankly, their productivity would decrease as they fell further behind on their workload. Now with Dexus, we can perform 3D analysis directly on the PACS on more patient cases due to the increase in speed of access and performance, which impacts the quality of patient care. In our facility, we estimate that in approximately 10% to 15% of high-tech imaging, 3D analysis will improve or change the diagnosis. Finally, training is a critical component and should not be overlooked. In my opinion, the best scenario is an intuitive system and software that doesn’t require significant training. The test of any training program is the extent to which staff can fully utilize the software while maintaining efficiency— two weeks after the training session is complete. Our radiologists expect the new environment will offer the referring physician, patient, and hospital (our employer) a better balance between accuracy, quality, and productivity. The way information from different systems and software is integrated does matter. We’ve learned that one software environment with a single database is critical for access to advanced imaging functionality and the entire diagnostic and image evaluation process. Remember, as radiologists, we are integrators of information, and the more our tools complete these tasks for us, the more efficient we can be in our diagnoses and consultations. n » www.gehealthcare.com/aw William P. Shuman, MD, is Director of Radiology at UWMC and Vice Chairman and Professor for the Department of Radiology. Dr. Shuman received his medical degree from State University of New York Syracuse and completed a residency in radiology at the University of Vermont. Dr. Shuman is one of the leaders in creating cardiac CT at UW. Outside of UW, Dr. Shuman has served as Associate Editor for two leading academic peer reviewed journals in radiology, is currently on the Appropriateness Committee of the American College of Radiology, and is the President of the Society of Body CT/MR. UW Medicine owns or operates Harborview Medical Center, University of Washington Medical Center, Valley Medical Center, Northwest Hospital & Medical Center, a network of seven UW Medicine Neighborhood Clinics that provide primary care, the UW School of Medicine, the physician practice UW Physicians, and Airlift Northwest. In addition, UW Medicine shares in the ownership and governance of Children’s University Medical Group and Seattle Cancer Care Alliance, a partnership among UW Medicine, Fred Hutchinson Cancer Research Center, and Seattle Children’s. The core hospitals, Harborview, UW Medical Center, and Northwest Hospital & Medical Center, together have about 69,000 admissions and about 1.4 million outpatient and emergency room visits to the hospitals and clinics each year. UW Medicine faculty includes four Nobel Prize winners, 33 Institute of Medicine members, 32 National Academy of Sciences members, and 16 Howard Hughes Medical Institute investigators. (Photo courtesy of UW Medicine.) 62 A GE Healthcare CT publication • www.ctclarity.com GE Healthcare Computed Tomography Great care by design. No company has done more to bring low dose to patients than GE Healthcare. That’s no coincidence — in fact, it speaks to the single purpose that guides our business: helping you deliver high-performance care. Our approach is built upon a foundation of low-dose technology. But it also encompasses the best practices and industry exposure we’ve amassed for decades. The result is a true end-to-end partnership designed to help you provide lower dose patient care, more efficiently, and more effectively. You’re here to deliver high-performance care. We’re here to help you do it. www.gehealthcare.com/LowDoseCT ASiR* Lower image noise while improving low contrast detectability and image quality. Partnership Decades of CT experience have made us a strong, dedicated partner who understands healthcare’s complexities Gemstone* Spectral Imaging Expand information for clinical diagnosis and workflow. © 2011 General Electric Company *Trademark of General Electric Company. tech n i ca l i n n o v at i o n Photon Counting Photon Counting: A New CT Technology Just Over the Horizon By Tibor Duliskovich, MD, Medical Director CT, GE Healthcare “CT is mature technology” is frequently heard, implying that CT has reached its full potential—that nothing revolutionary is coming down the road. This is simply not true. In a previous edition of CT Clarity magazine you may remember reading an article on dual energy CT and its clinical value and indications. Dual energy imaging, or in GE terminology “Gemstone Spectral Imaging” (GSI), uses two X-ray energies to allow improved differentiation of tissues and materials. It also enables virtual mono-energetic imaging. This post-imaging, processing technique mimics the use of a very narrow energy spectrum absorption and enhances material decomposition, making identifying and removing specific materials from image data possible. The GSI technique can also generate virtual un-enhanced images from a single contrast data acquisition. Clinical applications for GSI are still evolving and there is no doubt that radiologists will find new ways of utilizing the additional information that it provides. X-rays (and all frequencies of light) may be thought of as waves and particles. In fact, Albert Einstein won his Nobel Prize in physics for the work he contributed to understanding this wave/ particle duality, and not for his more famous work on the theory of relativity. Photon counting,** as the name implies, counts individual X-ray photons (the particles that make up the X-ray frequency light) hitting the surface of a single photosite of the detector—essentially, detecting individual events on a nanosecond scale! Unlike all existing technologies that digitize an integrated signal of an analog response of the detector to hundreds of events, photon counting counts discrete events (absorption of a single photon) and as such is “digital in nature” at the detection phase. Therefore, the electronic noise present in the detector is not sampled as it remains well below the signal level created by the thousands of electron-hole pairs generated by the impact of a single X-ray photon (Figure 1). This gives very clear input to the reconstruction algorithms. In fact, the detector resolution can be increased dramatically without a corresponding increase in statistical noise to achieve higher spatial and contrast resolution. But that is not all. The flexibility of photon counting allows other benefits as well, specifically leveraging the fact that the energy of the photons may be recorded in as many discrete ranges (bins) as necessary. Consider that in existing integrated detector technologies we have two energy spectra along with significant energy overlap between the two spectral bins (Figure 2). **Technology in development that represents ongoing research and development efforts. These technologies are not products and may never become products. Not for sale. Not cleared or approved by FDA for commercial availability. 64 A GE Healthcare CT publication • www.ctclarity.com Photon Counting t e c h n i c a l i nn o v a t i o n Figure 1. Experimental validation of photon counting vs. conventional CT acquisition. The impact of “zero electronic noise” is apparent in ultra-low dose CT acquisitions. At high doses the “pile-up” effect makes counting individual photons difficult and lowers efficiency of photon counting detector. Technique: 80 kV, 5 mAs, 32*0.625 mm, 0.5 sec axial, 10 mA, window width-1600 HU, window level-160 HU. The maximum energy for these is determined on the tube side by switching the kV. However, in photon counting the energy is discriminated on the detector side, so a single energy tube can do the job. By separating photons into a larger number of narrower energy bins, we can improve the mathematical reconstructions to approach better estimates of true mono-energetic images and not just simulate that effect mathematically as in the case of dual energies. The increase in the number of energy bins along with less energy contamination between the bins may improve the precision of material decomposition (Figure 3). This translates into higher-quality, virtual, un-enhanced images and the ability to remove materials selectively without “bleeding” into Figure 2. Different approaches to dual-energy acquisition: sequential acquisition and dual-tube detector techniques are prone to temporal mismatch. GSI effectively deals with temporal mismatch. Photon counting makes registration of all energy levels simultaneous and further improves energy separation. www.gehealthcare.com/ct • November 2011 65 tech n i ca l i n n o v at i o n photon counting Figure 3. Photon Counting Prototype Clinical Study: Full FOV abdominal imaging. Improvements in material decomposition allow for Z-map images that are color coded according to tissue atomic number. Efficient energy separation allows for true mono-energetic images. neighboring pixels or “contaminating” the data in the beam’s path. With this technique, voxels containing iodine (contrast agent) should be easily distinguished from non-contrast containing voxels, so true vessel lumen may possibly be identified and reconstructed in 2D and 3D with “suppressed” surrounding tissue. This data may possibly also be used for high-energy virtual reconstructions to calibrate PET standard uptake values more precisely in hybrid PET/CT scanners and to tailor therapeutic radiation treatment with the goal of better target delineation, hence sparing healthy tissue. Another potential benefit of detector-based photon counting comes from the fact that X-ray tubes continue to operate in standard conventional single-energy modes. All advanced X-ray tube technologies including mA modulation, kVp modulation, and focal spot modulation are planned to be used in photon counting scanners. Therefore, the tube voltage could be continuously modulated the same way we currently modulate the tube current to account for differences in absorption of the body from different angles. This may allow us to spare superficial tissues such as the breasts by turning down the mAs while simultaneously increasing the voltage. Based on the scout image data, it may also allow a dynamic optimization of imaging protocols and avoidance of so-called “photon starvation” in order to reduce overall dose while maintaining diagnostic image quality. Furthermore, a low kVp beam may be utilized on slim patients. The beauty of this technology is that the detector always operates in photon counting mode and the radiologist can decide after the fact whether to reconstruct a standard CT image or a photon 66 A GE Healthcare CT publication • www.ctclarity.com counting image out of the raw dataset without a need to rescan. So, for straightforward cases the exam could be fast and generate fewer images for speed and throughput, yet for difficult cases the radiologist would have a full arsenal of options to aid in determining the diagnosis. When not generating the photon-counting spectral images, the specifics of absorption of different energy photons at different depths enable precise weighting of each discrete energy level so that their contribution to a standard CT image can be fine tuned. As a result, we expect there will be better quality, standard CT images with less noise. The more energy bins we use in photon counting the closer we can get to true K-edge imaging of multiple elements simultaneously. Based on a specific “fingerprint” of a K-edge, i.e. the unique shape of its mass attenuation coefficient, the element can be identified with certainty (Figure 4). Tagging tumor cells with gold, tantalum, or other materials and subsequently utilizing photon counting technology holds hope for allowing reliable detection of very small, distant metastasis rivaling the sensitivity of PET with the spatial resolution of the most advanced CT scanners we have today. The counting of events happens on a nano-second scale, enabling extreme precision in recording the energy and time of the photon-material interaction. This information may be utilized to eliminate artifacts caused by the non-simultaneous acquisition of dual energy data, further improving image quality. P hoton C ounting t e c h n i c a l i nn o v a t i o n Figure 4. The identification of certain materials based on the unique shapes of their Mass Attenuation Coefficients (MAC). The sudden increase in X-ray attenuation at an energy level corresponding to the binding energy of K-shell electrons allows for 100% specific identification. All indications of GSI imaging are expected to be applicable to photon counting technology, as well. Additionally, scientists will likely develop numerous new applications, expanding the clinical utility of CT scanning and potentially allowing physicians to detect disease earlier and with more confidence. The ultimate goal is to improve patient outcomes. This article provides only a glimpse of things that may be coming in the not so distant future, possibly a few generations down the road. There are even more CT innovations and discoveries yet to come. Much hard work is needed to mature these new technologies and generate clinical evidence to support them, otherwise reimbursement and adoption will be a challenging hurdle. CT has amazing potential above and beyond the benefits it already provides! n References 1.J. Eric Tkaczyk, Rogerio Rodrigues, Jeffery Shaw, Jonathan Short, Yanfeng Du, Xiaoye Wu, Deborah Walter, William Leue, Daniel Harrison and Peter Edic, “Atomic number resolution for three spectral CT imaging systems”, Proc. SPIE 6510, 651009 (2007); 2.J. Eric Tkaczyk, David Langan, Xiaoye Wu, Daniel Xu, Thomas Benson, Jed D. Pack, Andrea Schmitz, Amy Hara, William Palicek, Paul Licato and Jaynne Leverentz, “Quantization of liver tissue in dual kVp computed tomography using linear discriminant analysis”, Proc. SPIE 7258, 72580G (2009); 3.J. Eric Tkaczyk, Kristian Andreini, Tan Zhang, Kevin G. Harding, Gil Abramovich, Yana Williams, Christopher A. Nafis and Wenwu Zhang, “CZT smart dicing strategy for cost reduction using defect imaging and random-access machining”, Proc. SPIE 7806, 78060L (2010); 4.J. Eric Tkaczyk, Vladimir Lobastov, Daniel D. Harrison and Adam S. Wang, “Contrast-to-noise of a non-ideal multi-bin photon counting x-ray detector”, Proc. SPIE 7961, 79613O (2011); 5.Adam S. Wang, Daniel Harrison, Vladimir Lobastov, and J. Eric Tkaczyk, “Pulse pileup statistics for energy discriminating photon counting x-ray detectors”, Med. Phys. 38, 4265 (2011); 6.Adam S. Wang, Norbert J. Pelc, “Synthetic CT: Simulating low dose single and dual energy protocols from a dual energy scan”, Med. Phys. 38, 5551 (2011); 7.Wang, A.S.; Pelc, N.J.; “Sufficient Statistics as a Generalization of Binning in Spectral X-ray Imaging“, Medical Imaging, IEEE Transactions on, 30 Issue:1, (2011) 8.Ehsan Samei, Norbert J. Pelc, “Impact of photon counting detector spectral response on dual energy techniques”, Proc. SPIE 7622, 76223L (2010); 9.Taguchi K, Zhang M, Frey EC, Wang X, Iwanczyk JS, Nygard E, Hartsough NE, Tsui BM, Barber WC.’ “Modeling the performance of a photon counting x-ray detector for CT: energy response and pulse pileup effects”, Med Phys. 38(2):1089-102, (2011) 10.Srivastava, S.; Taguchi, K.; “Improved contrast-to-noise ratio of photon counting clinical x-ray CT images using a model-selection based approach”, Nuclear Science Symposium Conference Record (NSS/MIC), 2010 IEEE 11.X. Wang, K. Taguchi, E. C. Frey, D. Meier, D. J. Wagenaar and B. E. Patt, “Material separation in x-ray CT with energy resolved photon-counting detectors”, Proc. SPIE 7961, 79611V (2011); Tibor Duliskovich, MD is Medical Director, Computed Tomography, at GE Healthcare. Dr. Duliskovich earned his medical degree from Semmelweis Medical University (Budapest) and was a staff radiologist at Haynal Imre Medical University (Budapest). He led Organizational and Methodological Department at the National Institute of Radiology and Radiation Physics in Hungary, where his department oversaw the design, manufacturing, installation and servicing of medical imaging devices to ensure safety and effectiveness. Prior to assuming his current position at GE, he has held various management positions at medical device and healthcare informatics companies, including DigiX, Inc., Wuestec, Inc., StorCOMM, Inc. Aspyra, Inc.; and Philips Healthcare. Dr. Duliskovich joined GE in January 2011, and in his medical affairs role supports regulatory submissions, marketing, scientific publications, patient safety, and the medical risk assessment process across the CT products; and helps align clinical research activities with business needs from a medical perspective. www.gehealthcare.com/ct • November 2011 67 b e y o n d the s ca n DOS E M A N A G E M E N T Comprehensive Dose Management Services and Solutions GE Healthcare has long recognized the benefits and risks of radiation in diagnostic imaging and continually strives to develop technologies and solutions to assist medical imaging providers in managing these risks. Earlier this year, the US Joint Commission issued a sentinel event alert on the radiation risks of diagnostic imaging,1 signaling that accrediting agencies (such as Joint Commission) may begin inspecting dose management, tracking, and reporting. Although dose management is an industry-wide patient care concern that requires a collaborative effort between physicians, facilities, and manufacturers, GE Healthcare offers several programs to help medical imaging providers improve patient care by better managing, tracking, and reporting dose. GE’s dose services and solutions assist a medical imaging provider to monitor and report dose, provide additional or refresher training for the facility’s staff, optimize protocols to enable low-dose studies, and perform quality control and quality assurance testing for regulatory and accreditation organizations. 68 A GE Healthcare CT publication • www.ctclarity.com DOSE M A N A G E M E N T Dose services and solutions For many healthcare facilities, particularly small- to medium-sized sites, capturing, reporting, and monitoring dose is a challenging task. Optimizing protocols to further lower dose may fall outside the realm of expertise for the facility’s staff. GE Healthcare offers a three-tiered approach to address clinical informatics, education and optimization, and medical physics. 1. Clinical informatics includes: DoseWatch, an information technology application that facilitates the tracking, reporting, and monitoring of dose from multiple manufacturers and multiple types of imaging devices; Innova Dose Reports for interventional fluoroscopy provides detailed analytics and alerts for the end user; and, integration with RIS and PACS to enhance patient care and facilitate the clinicians’ access to a patient’s dose exposure history by anatomy and utilize statistical data/benchmarking to identify opportunities for improvement. 2. Education and optimization services encompass training and protocol optimization support. 3. Medical physics solutions provide contract services for accreditation and periodic acceptance and local regulatory testing, technical support, and consulting. DoseWatch GE Healthcare now offers a comprehensive dose tracking and management system with DoseWatch. Through a facility’s existing network and IT infrastructure, DoseWatch captures dose information from imaging devices and organizes the data by modality and type of imaging protocol. The DoseWatch database stores all data, records dose by patient, and retains key acquisition parameters. In fact, after one year of using DoseWatch, CHU Strasbourg (France) reports a facility dose reduction due in part to using Dose Watch in their QA program. “We are all very pleased with the progress we have made using DoseWatch,” says Professor C. Roy, MD, Director of Radiology. “We conduct close to 100 CT exams each day, and thanks to DoseWatch we can get the dose information we need in a very useable format to help us better manage our imaging program.” Reference: 1. Available at: http://www.jointcommission.org/assets/1/18/SEA_471.PDF beyond the scan Joint Commission Sentinel Event Alert On August 24, 2011, the Joint Commission issued a Sentinel Event Alert on the dangers of medical radiation. The announcement also states that the Centers for Medicare & Medicaid Services (CMS) will require accreditation of facilities providing CT, MR, PET, and nuclear medicine in non-hospital sites beginning January 1, 2012. Additional accredited requirements may exist on a state-by-state basis. To view the alert, which contains suggestions by the Joint Commission for accredited facilities, visit http://www.jointcommission.org/assets/1/18/SEA_471.PDF With the dose monitoring solution, Professor Roy can evaluate dose management and optimization over a six-month period. She notes that DoseWatch interfaces directly to the CT system so it is transparent to the radiology workflow and does not slow down the examination time. Professor Roy is also impressed with the ability to access the patient’s dose history in a few mouse clicks. This is an important feature as many hospitals are concerned about the dose exposure for acute-care patients—many who require follow-up CT exams— and young adult or pediatric patients. Using DoseWatch, clinicians at CHU Strasbourg can help determine the appropriate dose level per procedure that can be shared throughout the imaging and interventional community. That’s because DoseWatch captures dose information during the procedure, and that data can then be used to help define dose targets by type of exam—such as neuro, abdomen, and thorax. As a result, the number of procedures that may have exceeded a predetermined dose level in the past have now been reduced at CHU Strasbourg. The bottom line, it is the patient who wins in terms of obtaining their diagnostic procedure at a dose that is ALARA. Adds Professor Roy, “Thanks to this software, we are now clearly below the target limits set out in the rules while maintaining the diagnostic quality exams we need. I believe that with DoseWatch, we have indisputably raised the overall quality of our medical imaging.” n » For more information on Dose Watch, visit www.gehealthcare.com/ResponsibleImaging. www.gehealthcare.com/ct • November 2011 69 b e y o n d the s ca n ct a n d r a d i at i o n d o s e Does my Patient Need a CT Scan? By Tibor Duliskovich, MD, Medical Director CT, GE Healthcare Today’s diagnostic imaging portfolio offers the clinician many options: ultrasound, MR, X-ray, SPECT, PET, fluoroscopy, and CT. In fact, each imaging modality visualizes different properties of human anatomy or function, and that is why these technologies are generally not completely interchangeable. 70 A GE Healthcare CT publication • www.ctclarity.com c t a n d r a d i at i o n d o s e During my radiology residency, I had a patient with metastatic liver disease that I diagnosed using ultrasound. The patient was taken to CT for a pre-operative scan and, given the technology available at the time, the lesions were not visible on the non‑contrast or contrast CT. My supervisor suspected I may have made a mistake until she repeated the ultrasound herself and verified my initial finding. Examples like this demonstrate what experienced clinicians already know—that each imaging modality has its strengths and weaknesses. This is why all the modalities have a complementary place in the differential diagnostic workup of a patient. Some may perform better than others in a particular case—it depends upon the patient’s needs and the clinical situation at hand. While the above example highlights a case where CT at that level of development was not the optimal diagnostic tool for a specific patient, rest reassured that CT is a vital clinical tool and is here to stay. In light of recent publicity over radiation from medical imaging, the public may have forgotten the reason we built the CT machines in the first place: to help clinicians accurately diagnose a multitude of life-threatening conditions promptly with virtually no contraindications. CT is used to determine emergency treatment pathways, diagnose pathology, monitor disease treatment, plan radiation therapy, calibrate nuclear medicine images, and much more. CT scanners help physicians make informed treatment decisions and save lives every day! Despite the clear benefits of CT, it is not the answer to all situations. Once a clinical decision is made to utilize medical imaging, physicians have an array of diagnostic procedures at their disposal. Because of this, many institutions follow evidence-based protocols, called appropriateness criteria, which take into account the advantages and disadvantages of each modality for a given clinical imaging task for that patient. By adhering to these guidelines, providers enhance the quality of care and contribute to the most efficacious use beyond the scan of different medical imaging modalities. These professional guidelines, such as those developed by the American College of Radiology,1 assist referring physicians and other providers in making the most appropriate imaging or treatment decision for a specific clinical condition. Ultimately, the healthcare professional has the responsibility to make the best decision for each individual patient and to select the proper diagnostic algorithm. A healthcare professional bases his/her decisions on the patient symptoms, the clinical question being assessed, the patient’s medical history, the presence of any contraindications to certain procedures or tests, and many other factors. If CT is deemed the best choice to achieve the optimal clinical outcome for the patient, the treating physician will prescribe a specific type of CT exam. The imaging department will carry out the prescription consistent with their best practices, available technology, and in accordance with the current state of medical practice. The single most important driving force behind prescribing a CT scan is that the benefit to the patient outweighs the risks, including the small risk of ionizing radiation, and no more appropriate alternative procedure is available to achieve the optimal clinical result. X-rays are ionizing radiation used in many imaging modalities to produce images. The image is formed by the portion of X-ray photons that are not absorbed in the patient’s body, but instead pass through it to the detector. This should make it clear why, without radiation, there is no CT image! If there is not enough radiation the result will be a “noisy” image, which may not be suitable for diagnosis. www.gehealthcare.com/ct • November 2011 71 b e y o n d the s ca n ct a n d r a d i at i o n d o s e This could lead to a repeat exam, a false positive finding requiring additional tests and a delay in diagnosis, or, even worse, a false negative finding. Repeating a CT exam would subject a patient to additional radiation and, in some instances, intravenous contrast. For these reasons, radiologists and technologists are trained to select the proper imaging protocols to answer the clinical question while keeping the patient’s radiation exposure under tight control. This is known as the ALARA (As Low As Reasonably Achievable) principle and it is fundamental to the appropriate use of CT and other imaging techniques that involve ionizing radiation. ALARA is based on the assumption that the amount of radiation utilized should always be the minimal amount required to achieve the desired result—a clinically useful image. Although there is no definitive evidence of harm caused by small amounts of radiation, such as the radiation levels received annually from so-called “background” sources (e.g., radon), minimizing radiation exposure is prudent. Therefore, the medical profession has adopted the no-threshold linear model of response to radiation, which assumes that the risk of exposure to ionizing radiation is cumulative over a lifetime and there is no threshold below which there are no potential effects. On the other hand, others have adopted a “heuristic” view of ionizing radiation, with some of the scientific literature supporting the notion that small amounts of radiation may be beneficial. Regardless of one’s view, the medical profession agrees that imaging should be justified, optimized, and in accordance with ALARA to minimize radiation exposure for patients. From my perspective as a radiologist, in order to best serve patients it is preferable to make a confident diagnosis rather than save a millisievert or two, as the correct diagnosis is a proven way to save lives. Patients typically feel the same way and readily support a recommendation for imaging after consultation with their physician about the risks and benefits of the exam. All CT manufacturers are investing in dose reduction technologies. GE Healthcare is leading the way with the design of X-ray tubes, collimation, dual energy, automatic beam modulation, detector technologies, and noise and artifact reduction algorithms. For more information on GE’s low-dose CT technology, see www.gehealthcare.com/LowerDoseByDesign. In addition, GE is incorporating the new MITA dose check feature on our CT scanners. It provides alerts and notifications to scanner operators when pre-defined radiation dose levels—as determined and set by the facility—will be exceeded. There are two levels of thresholds: Notification Values and Alert Values. Notification Values apply to a single image series (e.g. a single helical series) while Alert Values apply to a complete exam. CTDIvol and/or DLP (Dose Length Product) values can be set. This feature also is designed to check changes to protocols and keep a record if levels are exceeded. Furthermore, GE makes available personnel training and awareness of the relevance of dose reduction, and this is conveyed to customers during each interaction. Taking our commitment even further, GE is supporting a dozen or so clinical studies across the globe focused on specific clinical applications that are investigating pushing the dose limits even lower. These studies will provide us with clinical evidence to make crucial decisions on potentially reducing dose levels further while providing adequate clinical imaging. There are also new technologies on our horizon (see photon counting article on page 64) that may provide additional radiation dose reduction for our patients. In addition to technical innovation, GE actively participates in industry and professional groups working on national dose registries and other policy initiatives to support and expand the science behind CT for the benefit of our customers and their patients. n For a full list of references, visit www.ctclarity.com/ctclarity/201111#pg72. References 1. Available at http://www.acr.org/SecondaryMainMenuCategories/quality_safety/app_criteria.aspx Tibor Duliskovich, MD, is Medical Director, Computed Tomography, at GE Healthcare. Dr. Duliskovich earned his medical degree from Semmelweis Medical University (Budapest) and was a staff radiologist at Haynal Imre Medical University (Budapest). He led the Organizational and Methodological Department at the National Institute of Radiology and Radiation Physics in Hungary, where his department oversaw the design, manufacturing, installation and servicing of medical imaging devices to ensure safety and effectiveness. Prior to assuming his current position at GE, he has held various management positions at medical device and healthcare informatics companies, including DigiX, Inc.; Wuestec, Inc.; StorCOMM, Inc.; Aspyra, Inc.; and Philips Healthcare. Dr. Duliskovich joined GE in January 2011, and in his medical affairs role supports regulatory submissions, marketing, scientific publications, patient safety, and medical risk assessment process across the CT products; and helps align clinical research activities with business needs from medical perspective. 72 A GE Healthcare CT publication • www.ctclarity.com w o r l d w i d e e d u c at i o n beyond the scan Europe, Middle East, and Africa Clinical Education A clinical education specialist by your side whenever you need it Redefining applications training AppsLinq* is a new remote training service for troubleshooting and training that will help your CT department solve applicationrelated problems, improve efficiency, and develop important new skills. Enabled through broadband connectivity, a clinical education specialist can follow the CT console or AW workstation in real time through a secure Broadband connection. This allows CT application training to take place as if the clinical education specialist is in the imaging department by your side. » AppsLinq revisits traditional online training and places emphasis on practicality. It combines the hands-on benefits of on-site training with the convenience and fast response time of distance learning. Also, it allows training to be conducted in available time slots within the hectic schedule of an imaging department. Once the intial training on-site has been delivered, AppsLinq provides an ideal solution to complete your ongoing training in combination with technology and clinical classrooms. n For the latest information on training for Europe, Middle East, and Africa, visit www.gehealthcare.com/clinicaleducation. “I forgot how to…” Quick support to avoid patient flow disruptions “Help me with an advanced application...” Application support to prepare challenging exams Refresh training on CT or workstation applications Customized training sessions to best fit the day’s busy schedule www.gehealthcare.com/ct • November 2011 73 b e y o n d the s ca n w o r l d w i d e e d u cat i o n United States Clinical Education CT Masters Series The CT Masters Series are advanced training courses designed for radiologists, cardiologists, and radiologic technologists. The courses provide a unique opportunity for participants to learn from experts and receive individual attention in order to maximize their learning experience and ensure that they acquire the skills and confidence necessary for success. Training is offered in cardiac CT angiography, peripheral CT angiography, Gemstone Spectral Imaging, virtual colonoscopy, and CT dose reduction. The CT Masters Series curricula are designed with industry requirements in mind. The cardiovascular-focused courses are endorsed by the Society of Cardiovascular Computed Tomography (SCCT). n Cardiovascular Cardiac CTA: Advanced Course Matthew Budoff, MD Harbor UCLA Los Angeles, CA Peripheral CTA: Advanced Course Matthew Budoff, MD Harbor UCLA Los Angeles, CA CTA of the Coronaries: From Novice to Expert Tracy Q. Callister, MD, FSCAI Hyatt Place Hendersonville, TN Cardiac CTA: Beyond the Coronaries Tracy Q. Callister, MD, FSCAI Hyatt Place Hendersonville, TN 74 A GE Healthcare CT publication • www.ctclarity.com w o r l d w i d e e d u c at i o n beyond the scan India Clinical Education Healthcare in India, like many emerging economies, is challenged by the small population of trained radiologists and radiology technicians across the region’s vast geography. This lack of coverage is the main barrier to increasing access to healthcare in the region. To address this challenge, GE Healthcare’s South Asia CT Team is initiating a training program for radiology technicians in association with the Society of Indian Radiographers (SIR), the largest radiographer society in the region. The first residential training program is expected in the fourth quarter of 2011 with plans to initiate training programs at a later date for radiology consultants in advanced CT Technologies, such as low-dose CT imaging and Gemstone Spectral Imaging. For more information on CT Educational programs in South Asia, please email [email protected] n Low Dose Imaging Cardiac Imaging with CT: Advanced Certification CT Dose Reduction and Scanning Techniques Ronald P. Karlsberg, MD Mannudeep K. Kalra, MD Cardiovascular Medical Group of Southern California Beverly Hills, CA GE Healthcare Institute, Waukesha, WI Cardiovascular CTA for Technologists Joey Glass, RT(R)(CT) Cardiology Associates Mobile, AL Cardiovascular CTA for CT Technologists Rob Jennings, RT(R)(CT) Gemstone Spectral Imaging Gemstone Spectral Imaging Workshop James P. Earls, MD GE Healthcare Institute, Waukesha, WI Virtual Colonsocopy Judy Lane, RT(R)(CT) Virtual Colonoscopy for Radiologists Fairfax Radiological Consultants, P.C. Fairfax, VA Abraham H. Dachman, MD, FACR GE Healthcare Institute, Waukesha, WI For dates, CME information, and training opportunities, visit: www.gehealthcare.com/gectmasters or call 262-312-7148. www.gehealthcare.com/ct • November 2011 75 GE Healthcare More Clarity. Now on tap. Now you can have complete issues of GE Healthcare’s CT Clarity, the Magazine of CT, right at your fingertips when you’re on the go. The CT Clarity App links you to a vital source for the latest news about GE Healthcare CT on your iPad, iPhone, or Android tablet or phone. Download the free tablet and smartphone applications at the Apple Store (www.apple.com) or Android Market Apps (www.market.android.com). Or, simply scan the QR code below with your iPhone. Apple Follow us on Twitter: @GEHealthcare © 2011 GE Healthcare, a division of General Electric Company. iPhone and iPad are registered trademarks of Apple, Inc. Android is a trademark of Google, Inc. CT-0494-11.11-EN-US
Similar documents
imagination at work
information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services h...
More information